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ABSTRACT 
 
Lee Mangiante: The Role of Focal Adhesion Kinase in Vascular Smooth Muscle Cell 
Migration 
(Under the direction of Joan M. Taylor) 
 
Focal adhesion kinase (FAK) integrates diverse signaling pathways to regulate 
proliferation, migration, and differentiation.  Germline deletion of FAK in mice results in 
embryonic lethality with pronounced defects in vascular structure and integrity, 
implicating FAK as critical to the development and migration of vascular smooth muscle 
cells (SMCs).  However, the precise function of FAK in SMCs remains elusive.  Primary 
aortic SMCs from fakflox/flox mice were infected with Cre-expressing adenovirus, 
ablating FAK production.  FAK deletion inhibited migration to platelet-derived growth 
factor (PDGF).  While PDGF-induced membrane ruffling was FAK-independent, PDGF-
induced polarization was reduced fivefold in FAK-depleted cells.  The RhoA effector, 
Dia2, localized to focal adhesions in a FAK-dependent manner, and ablation of FAK 
attenuated myosin light chain phosphorylation. Finally, we detected a novel interaction 
between Dia2 and the Arp2/3 activator, cortactin.  These data suggest that FAK may 
promote cell contraction and polarized migration toward PDGF by regulating distinct 
pools of RhoA activity.  
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PREFACE: IF I NEVER SAW ANOTHER DORSAL RUFFLE… 
 
HORATIO  
O day and night, but this is wondrous strange! 
HAMLET  
And therefore as a stranger give it welcome. 
There are more things in heaven and earth, Horatio, 
Than are dreamt of in your philosophy. 
     Hamlet, Act 1, Sc. 5 
Upon reflection, my time at the University of North Carolina has been a series 
of mind-expanding events.  Before embarking upon the scientific pursuit contained 
herein, I had obtained some exposure to the world of science through my undergraduate 
research at the University of South Carolina.  I grew cancer cells in a dish; I looked at 
human tissues through a microscope; I separated proteins on a gel; I composed a thesis 
based on my findings.  I considered myself a fairly seasoned scientist at the ripe age of 
22, and ready to take the next step into graduate school.      
 My ensuing arrival at UNC, however, brought me back sharply to the reality of 
my own inexperience.  In the classroom, I hacked my way through dense forests of 
scientific literature, battled examinations the likes of which I had never seen before, and 
struggled to keep up with older, more experienced classmates.  In my rotations, I had to 
be babysat by unfortunate senior graduate students so that I could learn to do PCR 
mutagenesis, yeast two-hybrid screens, and DNA methylation analysis.  The academic, 
technical, and interpersonal challenges of my first year called for some serious 
adaptation on my part.         
 Really, though, the initial culture shock that necessarily accompanies the 
transition to graduate school pales in comparison to the mind-blowing things I’ve 
witnessed in the pursuit of cell biology.  I knew that cells had nuclei, organelles, and a 
cytoskeleton, but never before had I seen them with my own eye, lit up in gorgeous 
colors, and brought into striking relief through the power of a fluorescence microscope.  
I knew cells had to “remodel” their cytoskeleton to move, but I never appreciated how 
intricate and dynamic that process was until I watched it happen in real time.  I knew 
that cells were the basic units of all living things, but I never actually realized that cells 
are themselves alive, until I watched them going about their business over the space of 
days.  They crawl around, searching for nourishment, bumping into each other and 
turning away.  They can even take on personalities – some are big, fat, and sluggish; 
others are speedy little mischief-makers.       
 Truly, the things my cellular friends have shown me are beyond anything I ever 
dreamt of in my philosophy.  They have moved me to laughter with their antics, and 
inspired awe with their astounding beauty.  Despite their microscopic size, they have 
humbled me with their power, resilience, and complexity, and deepened my 
 vi
appreciation for the miracle that constitutes all life on earth.  Every step we take, every 
breath, every laugh, every gulp, every bat of an eyelash, every thought or memory or 
dream we ever have is the manifestation of a symphony of molecular events, refined 
over billions of years and executed with staggering precision.     
 I recall a conversation with a friend who joined a geophysics program after we 
left college.  His fieldwork and conventions were taking him to all sorts of exotic 
places.  He was always jaunting off to Hawaii, Romania, or some faraway paradise.  I 
once expressed envy at all the traveling he got to do, while I was stuck in the lab with 
my cells.  But then I realized I was just as much of a traveler as my friend was.  
Through the microscope, I have traveled to a universe that most people never get to 
see– a fast-paced, ever-changing, densely populated universe full of colorful characters.  
A universe with power plants, factories, shipping services, highways, banks, garbage 
dumps, libraries, police officers, construction workers, repairmen, and undertakers, all 
functioning in concert in a world only a few micrometers across.  This is the universe of 
the cell, and I am privileged to have been its inhabitant for the past three years.   
 Even if I never stare down the barrel of a microscope again, the lesson the cells 
have taught me will still ring true as Hamlet’s: keep an open mind, welcome new things 
though they be strange, and you might discover miracles underneath your very nose.  In 
essence, this is the true credo of the scientist, to which I hope to remain faithful 
wherever life takes me.            
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INTRODUCTION 
 
Smooth Muscle Cells in Vascular Development and Pathogenesis. 
Smooth muscle cells (SMCs) line all the hollow organs of the body.  Vascular 
SMCs, in particular, comprise the medial layer of large arteries, where they regulate 
blood pressure by controlling vessel tone.  Proper growth, migration, and differentiation 
of SMCs are critical to neovascularization, both during development and as part of the 
wound healing response. However, SMCs also play a pivotal role in the progression of 
several pathological states involving vascular occlusion, including atherosclerosis, 
restensosis, and hypertension.   
Platelet-derived growth factor, BB homodimer (PDGF-BB; hereafter PDGF), is a 
potent chemoattractant for SMCs in both a developmental and pathological context.  
Germline deletion of PDGF results in perinatal lethality, cardiovascular defects, and 
failed pericyte recruitment1-3.  PDGF signaling is also required for angiogenic sprouting 
and vessel enlargement, suggesting that this growth factor is critical for vasculogenesis.  
Further, release of PDGF at sites of injury recruits vascular SMCs for the purpose of 
repairing the damaged vasculature.  In the case of atherosclerosis, platelets respond to 
endothelial damage incurred by macrophages by releasing PDGF (Figure 1).  Medial 
SMCs, in turn, migrate towards PDGF and invade into the intima, occluding the arterial 
lumen4.  Thus, the migratory response of vascular SMCs toward PDGF can be viewed as 
a turning point in the pathogenesis of atherosclerosis, and is of great relevance to our 
understanding of cardiovascular disease.   
endothelium 
Figure 1.  SMC invasion in atherosclerotic lesion formation.  Fatty deposits along the arterial intima
are phagocytosed by inflammatory cells, resulting in endothelial cell damage and platelet recruitment.
Release of cytokines, eNOS, and PDGF stimulates proliferation and invasion of medial SMCs into the
intimal layer, resulting in occlusion of the arterial lumen.  
 
 
 
 
 
 
 
 
 
 
Focal Adhesion Kinase Signaling in Vascular Smooth Muscle Cells. 
Focal adhesion kinase (FAK) is a 125 kD nonreceptor tyrosine kinase that, while 
ubiquitously expressed, may play a special role in SMCs.  FAK can be divided into four 
major protein domains: an N-terminal integrin-binding domain; a central kinase domain; 
an SH3-binding domain; and a C-terminal focal adhesion-targeting domain5 (Figure 2).  
Although FAK can be phosphorylated at six different residues (Table 1)6,7, FAK 
activation is dependent on autophosphorylation at tyrosine 3978.  This 
autophosphorylation event enables binding to a number of SH2-containing proteins, 
including Src, PI3 Kinase, and Cas9.   
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Figure 2.  Protein domains
of FAK.  Integrins bind at the
N-terminus, stimulating
autophosphorylation of Y397
and facilitating protein-
protein interactions.  FAK is
localized to focal adhesions
via the C-terminal FAT
domain. 
 
FAK is classically understood as a transducer of integrin signaling.  Binding of 
integrins to extracellular matrix proteins such as fibronectin results in integrin clustering 
and activation of FAK via Y397 autophosphorylation10.  However, more recent evidence 
shows that FAK is also activated by several growth factors including PDGF, and 
contractile agonists such as angiotensin II4,11.  Autophosphorylation of FAK by these 
varied stimuli has been shown to activate numerous downstream signaling pathways, 
including the Rac-PAK-JNK and Ras-MEK-ERK pathways5,12.  Thus, FAK has emerged 
as both a critical structural anchor and a major signaling hub, capable of cooperating with 
growth factor receptors, G-protein-coupled receptors, and matrix protein receptors to 
impact multiple downstream pathways with varied biological consequences for the cell.   
Several lines of evidence suggest that FAK may play a unique role in SMCs.  
First, germline deletion of FAK in mice was shown to result in embryonic lethality by 
day E8.513.  FAK-null embryos exhibited a malformed mesoderm and anteroposterior 
axis, as well as poorly developed aortic and enteric arteries after day E813,14.  This 
vascular phenotype could reflect a defect in proper growth, differentiation, and/or 
migration of vascular SMCs.  In support of this, FAK has been shown to be necessary for 
PDGF-stimulated growth and migration of vascular SMCs15,16.         In addition, FAK has  
 3
 Tyrosine 
Residue Significance of Phosphorylation 
397 Creates binding site for Src family kinases, PI3 kinase, PLC gamma, SOCS, GRB7, p120 Ras GAP 
407 Required for binding of paxillin, vinculin 
861 Associated with enhanced p130Cas binding to FAK C-terminal domain; required for paxillin binding  
925 Creates binding site for GRB2 
576, 577 Promotes maximal catalytic activity of FAK 
 Table 1.  Tyrosine phosphorylation sites on FAK.  Autophosphorylation at residue 397 is the
best understood method of FAK activation.  Additional phosphorylation sites at 407, 861, and 925
facilitate binding of FAK to other proteins, while 576 and 577 lie within the “activation loop” that
helps maximize catalytic activity of FAK.     
been implicated in the regulation of vascular SMC contractility, possibly by facilitating 
increases in Ca2+ current17.  Finally, an endogenous dominant negative of FAK, termed 
Focal Adhesion Kinase-Related Non-Kinase (FRNK), is produced exclusively in 
SMCs18. FRNK is expressed at specific times during development and is upregulated 
following vascular injury18, indicating that FRNK expression in SMCs is significant at 
the organismal level, and suggesting that FAK requires a unique regulatory mechanism in 
SMCs.  As a whole, this body of knowledge suggests that a SMC-specific role of FAK is 
physiologically relevant and could have important consequences for our understanding of 
cardiovascular development and disease.   
 
FAK Signaling in Cell Migration. 
Studies using a wide variety of cell types have shown FAK to be a critical 
mediator of cell migration.  Depletion of FAK or inhibition of FAK activity impairs the 
adhesion-driven motility of fibroblasts, neurons, keratinocytes, endothelial cells, and 
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several tumor cell lines14,19-22. Further, emerging evidence indicates that FAK is critical 
for growth factor-induced motility, engaging in cooperative signaling between integrins 
and growth factor receptors23.  In SMCs, our group has shown that 3D migration towards 
PDGF-BB is blocked by adenoviral overexpression of FRNK.  Others have shown that 
FAK activation and cell migration is diminished in SMCs exposed to hypoxia24, and 
disruption of alpha integrin-mediated FAK activation results impedes SMC migration in 
vitro25.  Conversely, overexpression of FAK or enhanced FAK activity correlates with 
increased motility and tumor cell invasiveness26-28.  However, the structural and 
molecular events that underlie FAK-mediated migration remain elusive and exhibit 
substantial variation between cell types.   
Figure 3.  The cycle of cell migration.  Branched actin
polymerization facilitates lamellipodial protrusion at the
leading edge.  The cell polarizes by repositioning the nucleus
ss fiber-rich trailing edge of the cell.  Focal
contacts are assembled and disassembled at the leading edge.
sassembly of existing focal adhesions and contraction o
at the stre
Di f
the cell body enables retraction of the trailing edge. 
Cell migration can be understood as a cyclical progression of four biomechanical 
events: cell polarization and membrane protrusion at the leading edge; construction and 
deconstruction of new focal adhesions; contraction of the cell body; and retraction of the 
trailing edge29 (Figure 3).  
Several lines of evidence suggest 
a role for FAK in one or more of 
these events.  Fibronectin-
stimulated 3D migration, cell 
spreading, wound healing, and 
focal adhesion turnover are 
inhibited in FAK-null 
fibroblasts14,30. FAK-depleted 
keratinocytes also exhibit 
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impaired focal adhesion turnover, as well as a disorganized actin network and enhanced 
stress fiber formation20.  Randomly migrating endothelial cells, fibroblasts, and tumor 
cells display impaired lamellipodial extension and leading edge formation in the absence 
of FAK19,30.  FAK has also been implicated in microtubule organization of migrating 
neuronal cells31, as well as microtubule stabilization at the leading edge of migrating 
fibroblasts32.     
The proposed signaling events behind these structural phenomena are diverse, 
reflecting the multitude of proteins directly and indirectly impacted by FAK activity.  
Impaired focal adhesion turnover in FAK-deficient fibroblasts has been attributed to 
elevated Rho activity, possibly due to mislocalization of Src and p190 RhoGAP20,33.  
Conversely, it has been suggested that FAK-mediated focal adhesion turnover is 
dependent not on Rho, but on the GTPase dynamin34.  FAK has been reported to promote 
activity of the Rac1 GTPase via interaction with a Src/Cas/Crk/DOCK180 complex35, but 
more recent evidence suggests that FAK may inhibit localized Rac1 activity36.  
Photoactivation of a caged FAK peptide halts lamellar extension, putatively by 
competitive binding of Src and PI3 Kinase37.  In conclusion, while some consistencies 
have emerged, it is clear that the role of FAK in migration depends largely upon cell type 
and migratory stimulus. 
 
Remodeling of the Actin Cytoskeleton During Cell Migration. 
 Cell migration represents the dynamic integration of myriad molecular events to 
promote the structural changes and mechanical forces necessary for movement38.  The 
processes of polarization, lamellipodial extension, and focal adhesion formation/turnover 
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all require the concerted remodeling of various cytoskeletal components.  Of these 
players, the most extensively studied is actin.  Polymerized actin is important for the 
formation of numerous motile structures39.  Long, unbranched bundles of actin form 
filopodia, which function as transient sensory extensions for the cell.  Unbranched actin 
bundles also constitute large cable-like structures called stress fibers (Figure 4), which 
aid in structural support and contractility, and are particularly abundant in SMCs.  
Alternatively, actin can form as a network of branched filaments, thereby promoting 
lamellipodial protrusion and membrane ruffling, both of which require localized clearing 
of stress fibers. 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Unbranched and branched actin networks in migrating SMCs.  Left: Actin stress
fibers, stained by phalloidin (red), are bundles of unbranched actin that provide structural support and
facilitate contractile force.   Branched actin, highlighted by cortactin (blue), promotes protrusion at
the leading edge.  Note that stress fibers are cleared around sites of branched actin, and rich in the
tapered trailing edge.  Right: 100x magnification of phalloidin staining illustrates the cleared region
(asterisks) between stress fibers and unbranched actin at the edge of a protruding lamellipod. 
*
* 
In addition to driving protrusion at the periphery of the cell, branched actin also 
promotes several types of specialized structures, including podosomes, invadopodia, and 
dorsal ruffles40.  Dorsal ruffles are so called because they form on the dorsal surface of 
*
*
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the cell membrane.  PDGF is a classic trigger of dorsal ruffle formation in multiple cell 
types, although epidermal and hepatocyte growth factors can also elicit this response.   
Two decades after their discovery, the biological function of dorsal ruffles 
remains unclear.   Originally, they were thought to be important for generating force to 
drive cell motility.  More recent evidence indicates that dorsal ruffles may facilitate 
lammelipodial extension by clearing stress fibers at the leading edge of the cell, or 
promote invasion by degrading the extracellular matrix.  It has also been proposed that 
dorsal ruffles might function in the processes of macropinocytosis and internalization of 
ligand-bound growth factor receptors.  
 
 
 
 
 
 
 
Figure 5.  Dorsal ruffles in a PDGF-
treated SMC.  Cortactin (red), which
drives branched actin polymerization,
localizes to dorsal ruffles as soon as 2
minutes after PDGF treatment, and
ruffling usually subsides by 30
minutes.  Stress fibers (phalloidin,
green) are generally cleared in the area
immediately surrounding a dorsal
ruffle.     
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Rho Family GTPases: Master Regulators of the Cytoskeleton. 
 
The Rho family of small GTPases consists 
of ten members, the best characterized of which 
are Rho, Rac, and Cdc42.  Like other small 
GTPases, the Rho GTPases act as dynamic 
molecular switches within the cell, oscillating 
between a GDP-bound, or inactive, state, and a 
GTP-bound, or active, state (Figure 6).  These 
enzymes are tightly regulated by three classes of 
molecules. GTPase Activating Proteins (GAPs), which enhance GTP hydrolysis, and 
Guanosine Nucleotide Dissociation Inhibitors (GDIs), which sequester GDP-Rho, act as 
negative regulators of Rho GTPase signaling.  Conversely, Guanosine Nucleotide 
Exchange Factors (GEFs) promote the transition of GDP-Rho to GTP-Rho, facilitating 
effector binding and downstream signaling41.   
Figure 6. Regulation of Rho GTPases.
GEFs facilitate Rho signaling by
exchanging GDP for GTP.  GAPs and
GDIs inactivate Rho by promoting the
GDP-bound state. 
A wealth of evidence has implicated the Rho GTPases as master regulators of 
cytoskeletal remodeling, as they impact multiple biological processes including 
migration, cytokinesis, phagocytosis, and axonal guidance.  Rho activity has been shown 
to promote stress fiber formation, focal adhesion formation, and cell contractility.  Rac 
signals to several activators of the Arp2/3 complex, including WAVE1/2, PI3 Kinase, 
and cortactin, thereby promoting branched actin polymerization, membrane ruffling, and 
lamellipodial extension.  Finally, Cdc42 is associated with polarity establishment and 
filopodia formation41.  
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The Diaphanous-Related Formins in Cell Migration. 
 
The Diaphanous-Related Formins (DRFs) are the best-characterized group of the 
formin family of proteins, and consist of three members in mouse, termed mDia1, mDia2, 
and mDia3.  Like all formins, the DRFs actively promote polymerization of unbranched 
actin via a conserved formin homology 2 (FH2) domain, and all three DRFs are effectors 
of the small GTPase RhoA42.   
Figure 7.  Schematic of the DRF Dia2.  Dia2 is kept in an inactive 
conformation via an intramolecular DID-DAD interaction.  Binding 
of GTP-Rho to the GBD disrupts this interaction, allowing Dia2 to
assume an open conformation and to promote actin polymerization.  
The DRFs can be divided into a regulatory N-terminal half and an actin-
polymerizing C-terminal half42 (Figure 7).  The N-terminal portion contains the GTPase 
binding domain (GBD), the Diaphanous Inhibitory Domain (DID), and the formin 
homology 3 (FH3) domain, which contains a dimerization domain.  The C-terminal 
portion contains the FH1 
domain, which binds 
profilin, the FH2 domain, 
which binds monomeric 
actin, and the Diaphanous 
Autoinhibitory Domain 
(DAD).  It is thought that 
DRF activity is regulated 
via an intramolecular 
interaction between the 
DID and the DAD,      
whereby the DRF is kept in 
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a closed (inactive) conformation.  Binding of active Rho to the GBD disrupts the DID-
DAD interaction, whereupon the DRF assumes an open (active) conformation.  In the 
active conformation, the FH1 and FH2 domains are exposed, allowing the DRF to 
complex with profilin, an abundant cytosolic protein that binds ATP-actin, and 
subsequently to nucleate actin filament assembly43.  
Through their actin remodeling activities, the DRFs impact a variety of cellular 
processes, such as cytokinesis, polarity establishment, endocytosis, and 
differentiation42,44.  Not surprisingly, the DRFs also play a substantial role in cell 
adhesion and migration.  Dia has been shown to localize to the tips of filopodia in 
multiple cell types45,46. Dia1 has also been implicated in stress fiber formation47, focal 
adhesion formation, and focal complex maturation48,49.  It has also been shown that Dia 
targets microtubules to focal adhesions, thereby limiting focal adhesion growth and 
promoting turnover50.  While very little is known about a connection between Dia and 
FAK, it was previously shown that Dia1 is required for microtubule stabilization at the 
leading edge of migrating fibroblasts, and that this process is dependent on FAK 
activity32.  It has also been proposed that Dia promotes focal adhesion turnover by 
targeting Src to focal adhesions.51 Existing data indicates that Src promotes focal 
adhesion turnover by interacting with FAK52,53, suggesting possible interplay between 
Src and Dia in this process.   
Our group has found that ablation of FAK promotes transcription of SMC-
specific genes (unpublished data).  Coupled with the requirement of FAK for SMC 
migration, this suggests that, in SMCs, enhanced FAK activity correlates with a less 
differentiated, pro-migratory phenotype, while dampened FAK activity promotes a more 
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differentiated, anti-migratory phenotype.  Since Dia2 activity has been shown to promote 
expression of SMC marker genes44,54, as well as migration of other cell types, it will be 
interesting to investigate whether FAK might determine the biological consequence of 
Dia activity in SMCs.   
 
Cortactin in Actin Polymerization and Cell Migration. 
Cortactin is an SH3 domain-containing protein that directly activates the Arp2/3 
complex55 and stabilizes the branch points of the resultant branched actin filaments  
(Figure 8)56.  Cortactin was originally identified as a Src substrate in transformed cells 
and shown to localize to peripheral membrane ruffles, lamellipodia, and podosomes57,58.  
Recently, the roles of cortactin as a promoter of branched actin polymerization and as a 
Src target have been unified by the discovery that phosphorylation of cortactin by Src 
enhances branched actin assembly59.  In response to activation of growth factors and 
integrins, cortactin is robustly recruited to peripheral and/or dorsal ruffles, where it drives 
branched actin polymerization.60  
 
 
 
 
 
 
 
Figure 8.   Regulation and
biological activity of cortactin.
Activation of growth factor
receptors and integrins leads to
activation of SFKs and
phosphorylation of cortactin.  In
its activated state, cortactin is
recruited to the membrane, where
it cooperates with Arp2/3 to
polymerize branched actin. 
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Rac1 activity is necessary and sufficient for cortical translocation of cortactin, and 
is also required for the phosphorylation of the major Src phosphorylation sites61,62.  As 
one might expect, evidence suggests that cortactin plays an important role in cell 
migration.  Knockdown of cortactin by siRNA inhibits transwell migration, invasion, and 
random motility in fibrosarcoma cells.  Additionally, cortactin silencing results in 
lamellipodial instability and impaired focal adhesion assembly at areas of protrusion63.  
Conversely, overexpression of cortactin correlates with enhanced motility and metastatic 
potential in transformed cells64,65.  Although cortactin has not been shown to localize to 
focal adhesions, it is phosphorylated upon integrin engagement66, and regulates spreading 
and intercellular adhesion of cancer cells67.  While a connection between FAK and 
cortactin has not been extensively explored, it was recently shown that FAK is required 
for phosphorylation of cortactin by Src during internalization of integrin-binding S. 
aureus68.  Thus, it appears that cortactin, like FAK, can transduce integrin and growth 
factor signals and in some contexts, may depend on FAK to mediate cytoskeletal 
rearrangement. 
 
Summary.   
 The process of cell migration represents a precisely coordinated cycle of 
structural events involving a host of molecular players.  A substantial body of evidence 
has implicated FAK as a key facilitator of several of these events.  The goal of the 
following work was to elucidate the specific role of FAK in SMC migration.  In 
undertaking this project, I focused on intracellular signaling by the Rho subfamily 
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GTPases.  Cortactin and mDia2, which function downstream of Rac1 and RhoA 
respectively, emerged as components of particular interest in this work.       
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EXPERIMENTAL PROCEDURES 
 
Cell Culture and Adenoviral Infection. Aortic smooth muscle cells were isolated 
from thoracic aortas of 8-week FAKflox/flox mice by enzymatic digestion as described 
previously69.  Cells were used from passages 7–21 and were maintained in Dulbecco’s 
modified Eagle’s medium-F-12 (1:1) plus 10% fetal bovine serum and 1% penicillin-
streptomycin.  LacZ- and Cre-expressing adenoviruses were obtained from the University 
of Iowa Gene Transfer Vector Core, and were expanded and purified using the 
Adenopure kit (Puresyn).  Cells were infected with adenovirus 24 hours after plating.  All 
PDGF treatments occurred 72 hours after adenoviral infection.  Latrunculin B was 
purchased from Calbiochem, and administered for 1 hour at 0.5 uM.      
Antibodies. Antibodies to the FAK N-terminus, ERK1/2, cortactin, pAKT1 
(Ser473), and Rac1 were obtained from Upstate.  Anti-phospho-PDGF receptor β was 
also purchased from Upstate, and used at 1:500 for IHC.  All antibodies were used at a 
dilution of 1:1000 for western blot.  Anti-FAK and anti-cortactin were used at 1:500 for 
immunofluorescent staining.  Anti-RhoA was obtained from Santa Cruz Biotechnology 
and used at a dilution of 1:250 for western blot.  The antibody to phosphorylated myosin 
light chain was purchased from Cell Signaling and used at a dilution of 1:1000 for 
western blot.  The vinculin antibody was from Sigma, and used at a dilution of 1:500.  
The antibody to detyrosinated tubulin was purchased from Millipore, and used at 1:1000 
for western and 1:500 for IHC.  Texas Red- conjugated anti-mouse IgG was purchased 
from Jackson Immunoresearch, and FITC-conjugated phalloidin was purchased from 
Molecular Probes.  Polyclonal anti-GFP and anti-Flag M2 were purchased from Clontech 
and Sigma, respectively, and were both used at 1:1000 for western blot.   
3D Migration Assays. FAKflox/flox   mouse aortic SMCs were infected with LacZ 
or Cre adenovirus as described above. Cells were washed in PBS (calcium- and 
magnesium-free), trypsinized, and collected in PBS containing soybean trypsin inhibitor 
(1 mg/ml). Cells were pelleted at 2500 rpm and resuspended in serum-free DMEM-F12 
containing 0.1% fatty acid-free BSA (Sigma). Cells were plated on 8 uM transwell inserts 
(BD Biosciences), which were coated with fibronectin (10 ug/mL, Sigma). The bottom 
well was filled with serum-free DMEM-F12 containing 0.1% BSA and vehicle or PDGF-
BB (20 ng/ml, Calbiochem). Chambers were incubated at 37°C for 7 h. Chambers were 
rinsed with PBS and fixed in 4% paraformaldehyde for 20 min. Cells were removed from 
the top chamber by scraping with a cotton swab, and the remaining cells (in the bottom 
chamber) were stained with 1% crystal violet and counted.  
Immunofluorescent Staining.. Cells were plated on Lab Tek II chamber slides 
(Nunc) and infected with LacZ- or Cre-expressing adenovirus as described above.  Prior 
to PDGF treatment, cells were starved overnight, then re-starved for 4 hours the 
following morning.  Slides were fixed in 4% paraformaldehyde for 20 minutes (or 100% 
methanol for 5 minutes for microtubule staining), washed thrice in PBS, then 
permeabilized for 3 minutes with 0.4% Triton X-100 in PBS. Following 
permeabilization, nonspecific staining was blocked via 30 minute incubation in PBS 
containing 20% goat serum and 3% BSA.  Cells were incubated with primary antibody in 
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blocking solution for 1 hour, washed thrice with PBS, then incubated for 1 hour in PBS 
containing Texas Red goat anti-mouse IgG (1:1000) and FITC-conjugated phalloidin 
(1:400).  Secondary antibody was removed via three washes in PBS and one wash in 
distilled water prior to coverslipping.  All steps were performed at room temperature. 
Microscopy and Kymographic Analysis. Fluorescence images were generated 
using an Olympus BX51 for fixed cells and an Olympus IX70 for live cells.  Images were 
acquired at 40x magnification by a CoolSnap FX CCD camera (Photometrics) using iSee 
software (Isee Imaging Systems).   
Rho Family GTPase Activity Assays. LacZ- and Cre-infected SMCs were starved 
for 48 hours, then treated with PDGF and lysed in Rho Buffer A (50 mM Tris pH 7.6, 
500 mM NaCl, 0.1% SDS, 0.5% deoxycholate, 1% Triton X-100, 10 mM MgCl2) 
containing 100 μM leupeptin, 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride 
hydrochloride, 20 ug/mL soybean trypsin inhibitor, and 0.05 trypsin inhibitory units/ml 
aprotinin.  Lysates (600 ug-1mg for RhoA; 200-500 ug for Rac1) were rotated with 40 ug 
of immobilized GST-Rho binding domain (RBD) or 30 ug GST-p21 binding domain 
(PBD) for 30 minutes at 4ºC, then washed three times with Rho Buffer B (50 mM Tris 
pH 7.6, 150 mM NaCl, 1% Triton X-100, 10 mM MgCl2 containing the protease 
inhibitors listed above.  Complexes were pelleted by centrifugation, boiled in SDS-PAGE 
buffer, electrophoresed (15% SDS-PAGE) and transferred to PVDF membrane.  Western 
Blots were performed for Rac1 or RhoA.   
GST Pull-Down Assay. GST-FH2 (amino acids 596-1030 of Dia2) and GST-
FH1FH2 (amino acids 532-1030 of Dia2) was purified from bacterial lysates using 
glutathione-agarose beads (Amersham Biosciences) as described previously (16). Cells 
 17
were lysed in Buffer A (50 mM Tris, pH 7.6, 500 mM NaCl, 0.1% SDS, 0.5% 
deoxycholate, 1% Triton X-100, 0.5 mM MgCl2) containing 10 mM beta glycerol 
phosphate,  40 mM NaF, 1 mM Na3VO4, and 1 ug/mL microcystin, and protease 
inhibitors described above.  Lysates were cleared by centrifugation for 10 min at 14000 
rpm at 4°C and protein concentrations determined. 1 mg of SMC lysate was combined 
with 10 ug of GST-FH2 or GST-FH1FH2, and samples were rotated at 4 °C for 2 hrs. 
The complexes were pelleted by centrifugation and washed thrice in Buffer A containing 
protease and phosphatase inhibitors, then once in 1X TBS. Samples were boiled in SDS-
PAGE buffer, electrophoresed (10% SDS-PAGE gel), and transferred to nitrocellulose 
membrane. Western blotting was performed using an anti-cortactin primary antibody as 
described above. 
 Coimmunoprecipitation.  COS-7 cells were cotransfected with GFP and Flag 
empty vectors, or with GFP-cortactin and Flag-Dia2, then lysed in NP-40 buffer (1% NP-
40, 0.5% Triton-X100, 200 mM EDTA, 0.15 M NaCl, and 50 mM Tris-Cl, pH 7.2) 
containing protease and phosphatase inhibitors as described above.  Lysates were cleared 
by centrifugation and protein concentrations determined.  1 mg of lysate was rotated with 
35 uL of Flag-M2 agarose beads (Sigma) overnight at 4C.  Complexes were pelleted by 
centrifugation, then washed twice in NP-40 buffer containing protease and phosphatase 
inhibitors, and once in 1X TBS.  Complexes were resuspended and boiled in SDS-PAGE 
sample buffer, then electrophoresed on an 8% polyacrylamide gel and transferred to a 
nitrocellulose membrane.  Membrane was blocked in 5% milk for 1 hour, and western 
blot for GFP and Flag was performed as indicated above.       
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Plasmids. All Dia2 constructs were generously provided by Dr. Christopher 
Mack, and mCherry paxillin was a generous gift of Dr. Klaus Hahn (Dept. of 
Pharmacology, UNC-Chapel Hill).  pEGFP-cortactin was kindly contributed by Dr. 
James Bear (UNC-Chapel Hill).  WAVE2 was purchased from Open Biosystems and 
subcloned into pEGFP (Promega).   
 Statistical Analysis.  For transwell migration assays, the average number of 
migrated cells per well was calculated from a raw count from four separate fields within 
the well.  Each condition was conducted in duplicate.  For dorsal ruffling and polarization 
quantification, the percentage of cells exhibiting dorsal ruffles or the percentage of 
polarized cells was calculated from seven fields per slide.  For densitometry of glu-
tubulin levels, intensity levels for each band were calculated using NIH ImageJ, then 
normalized to the corresponding intensity of ERK for each lane.  Data shown represents 
the average of three western blots.  For all experiments, p value was calculated using a 
student’s unpaired t-test.     
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RESULTS 
 
Effects of FAK depletion on SMC biology. 
 To conditionally ablate FAK in primary SMCs, we have used a published mouse 
model termed the fak-flox mouse70, in which loxP sites flank the ATP-binding domain of 
fak exon 20 (Figure 9A).  In the presence of Cre recombinase, these loxP sites are cleaved 
and FAK protein is no longer produced.  We isolated aortic SMCs from 8-week 
FAKflox/flox   mice and used a replication-deficient adenoviral construct to express Cre 
recombinase in cultured cells.  At 72 hours after viral treatment, FAK expression was 
effectively ablated in SMCs infected with Cre-expressing virus, but not in those infected 
with LacZ-expressing virus (Figure 9B-C).  Notably, FAK- SMCs exhibit comparable 
cell spreading and cytoskeletal arrangement to their FAK+ counterparts, contrasting with 
reports of impaired spreading and aberrant actin structures in endothelial cells, 
fibroblasts, and keratinocytes following fak deletion.  Additionally, vinculin staining 
reveals similar focal adhesion size in FAK-containing and FAK-depleted SMCs (Figure 
9D), suggesting that the formation and turnover of these structures is unperturbed in 
randomly migrating FAK- SMCs.  These preliminary observations support the idea that 
the role of FAK in SMCs is different from its role in other cell types.   
 
 
  
Figure 9.  Conditional depletion of FAK in cultured SMCs.  A. Schematic depecting the fak gene in
the fak-flox mouse.  B-D.  Primary aortic SMCs from 8-week FAKflox/flox  mice were infected with either
Cre-expressing or LacZ-expressing (control) adenovirus.  Cells were fixed and imaged (B,D) or lysed
(C) 72 hours post-infection.           B. SMCs were fixed in 4% paraformaldehyde and immunostained
with anti-FAK (red) and phalloidin (green).  C. SMC lysates were separated by SDS-PAGE, and probed
for FAK and ERK via western Blot.  D. SMCs were fixed and immunostained with anti-vinculin (red)
and phalloidin (green).       
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 Because FAK has been linked to multiple cellular processes, including 
prolifer
 
ation, apoptosis, migration, and differentiation, we investigated the consequences 
of FAK ablation on these fundamental aspects of SMC biology.  A WST-1 assay, which  
measures cell viability based on mitochondrial function, showed no significant difference
in the viability of Cre- and LacZ-infected FFSMCs (Figure 10A).  Further, FAK 
depletion had no effect on mitogen-stimulated cyclinD1 expression (Figure 10B), 
indicating that FAK is not required for SMC proliferation or most likely cell survival.   
To assess the impact of FAK depletion on apoptosis, I quantified the activity of caspases 
3 and 7, which are early-stage effectors of the apoptotic pathway.  At 72 hours post-
infection, caspase 3/7 activity was not significantly different in FAK+ and FAK- cells 
(Figure 10C), suggesting that FAK depletion has no detectable effect on SMC apoptosis.   
 
 
 
 
 
 
 
 
 
 
 
Figure 10.  Depletion of FAK has no effect on
SMC growth or apoptosis.  A.  LacZ- and Cre-
infected SMCs  were untreated (control) or treated
with 20 ng/mL PDGF (Calbiochem).  Viability was
measured using a WST-1 assay (Roche).  Data
courtesy of Joan Taylor.  B. Infected SMCs
received no treatment (0), PDGF (BB), or 10% fetal
bovine serum (SM).  Protein expression was
analyzed via western Blot.  Data courtesy of Liisa
Smith.  C.  Infected cells were maintained in serum-
containing media (10% SM) or serum-starved for 16
hours (SFM), and caspase activity was quantified
using the CaspaseGlo assay (Promega).   
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To analyze directed migration of F K-containing and FAK-depleted SMCs, I 
used a
 
A
 transwell assay, in which cells crawl through a porous membrane toward a 
chemoattractant.  Interestingly, fibronectin alone was insufficient to stimulate SMC 
migration, underscoring the unique migratory behavior of SMCs as compared to the more 
extensively studied fibroblasts.  While FAK depletion only slightly impaired SMC 
migration towards 10% serum (Figure 11A), it dramatically inhibited PDGF-stimulated 
migration (Figure 11B), suggesting that FAK is critical for this specific agonist signaling 
pathway. Overexpression of wild-type FAK rescued the ability of FAK- SMCs to migrate 
towards PDGF (Figure 11C).  However, overexpression of FAK Y397F, which cannot be 
phosphorylated at tyrosine residue 397, failed to rescue the migratory defect, indicating 
that this major phosphorylation event is critical to PDGF-stimulated SMC migration.   
 
 
 
 
 
 
 
 
 
 
 
Figure 11.  Impaired 3D migration in FAK-depleted SMCs.  A-C.  LacZ- or Cre-infected cells
were plated on fibronectin-coated inserts (BioC allowed to migrate toward 10% FBS (A,oat) and 
courtesy of Liisa Smith), 20 ng/mL PDGF (B,C) for 7 hours.  Cells were counted in four fields and
averaged. (C) LacZ- or Cre-infected cells were cotransfected with GFP and Flag, GFP and Flag-FAK,
or GFP and Flag-FAK Y397F.  Twenty-four hours after transfection, chemotaxis was assayed as in
(A).  The number of migrated GFP-positive cells after 7 hours was normalized to the number of
attached GFP-positive cells after 1 hour to account for differences in transfection efficiency.  Dats
shown in (C) provided courtesy of Joan Taylor.  
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To ensure that FAK was not required for localized activation and/or turnover of 
the PDGF-β receptor, I performed immunofluorescent staining using an antibody specific 
to the phosphorylated PDGFR.  Both LacZ- and Cre-infected cells demonstrated intense 
staining at peripheral and dorsal membrane ruffles following PDGF treatment (Figure 
12A), indicating that PDGFR activation and turnover are FAK-independent processes.  
Also, PDGF-stimulated ERK activity is not significantly different between FAK+ and 
FAK-null cells (Figure 12B), supporting the findings that PDGF-stimulated growth is 
intact in these cells.       
 
Figure 12.  PDGF receptor activation is FAK-independent.  A. SMCs were 
 
 
 
 
 
 
 
 
 
 
 
 
serum
 starved for 16 hours, treated with 20 ng/mL PDGF for 5 minutes, fixed in paraformaldehyde,
and stained with anti-phospho-PDGF receptor beta (green) and phalloidin (red).  B. Cells
were starved as in (A), and treated at indicated timepoints.  Lysates were separated by SDS-
PAGE and probed via western Blot for phospho-ERK1/2 (Upstate).      
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PDGF-induced membrane ruffling and cell polarization. 
 SMCs to migrate three-
dimens
B. 
Given the dramatic inability of FAK-depleted
ionally to PDGF, we used immunfluorescent staining to visualize PDGF-induced 
actin remodeling in a two-dimensional context.   Both LacZ- and Cre-infected SMCs 
demonstrated dramatic peripheral and dorsal membrane ruffling following PDGF 
treatment (Fig. 13A).  These ruffles colocalized with cortactin, and stress fibers were 
cleared in the immediately surrounding area.  Additionally, the dynamics of dorsal ruffle 
formation were similar in the presence and absence of FAK, with the response initiating 
around 2 minutes, peaking around 5 minutes, and subsiding by 30 minutes (Fig. 13B).   
 A. LacZ Cre
 
 
 
 
 
 
 
 
 
 
   
 
Figure 13. PDGF-induced dorsal and peripheral membrane ruffling is unimpaired by FAK
depletion.  LacZ- or Cre-infected SMCs were serum starved for 16 hours, treated with PDGF-BB
(20 ng/mL) and fixed in 4% paraformaldehyde at indicated timepoints. A. Cells were stained with
 phalloidin (green) and anti-cortactin (red).  Images shown are at 40x magnification. B. The
percentage of cells exhibiting dorsal ruffles was calculated for seven fields per slide.  At 7.5
minutes post PDGF, the difference in ruffling was not significant (p = 0.13).    
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Taken together, these observations indicate that cortactin-mediated branched actin 
embrane protrusion, a critical step in migration is polarization of the 
cell bo
polymerization and subsequent membrane protrusion are uninhibited in the absence of 
FAK.   
Along with m
dy29, as it dictates the directionality of cell movement.  Importantly, it has been 
shown that a distinct chemotactic gradient, such as that established in a transwell assay, is 
not required for cell polarization38.  Consistent with this, we observed dramatic SMC 
polarization following PDGF treatment in a two-dimensional system, regardless of the 
homogenous distribution of agonist.  Interestingly, FAK- cells appeared markedly less 
polarized following PDGF stimulation (Figure 14A).   
 
 
 
 
 
 
 
 
. 
 
 
 
 
Figure 14. PDGF-
induced cell
polarization is reduced
five-fold in FAK-
SMCs. LacZ (blue)- or
Cre (red)-infected SMCs
were serum starved for
16 hours, treated with
PDGF-BB (20 ng/mL)
and fixed in 4%
paraformaldehyde at
indicated timepoints. A.
Cells were stained with
phalloidin (green) and
anti-cortactin (red).
Images shown are at 40x
magnification. B.
Polarized cells were
counted in seven fields
per slide, then averaged.
For all timepoints shown,
p≤ 0.01.     
 
 
B. 
     LacZ CreA. 
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Polarized FAK+ cells were characterized by a broad, cortactin-rimmed leading 
edge a
PDGF-induced Rac1 signaling in FAK-depleted SMCs. 
K can facilitate cell motility by 
regulat
nd a stress fiber-rich, tapered trailing edge, while FAK- cells formed some 
cortactin-containing lamellapodia, but failed to form the clear leading and trailing edges 
indicative of directional movement.  Quantitatively, polarization following PDGF 
treatment was reduced approximately five-fold in the absence of FAK (Figure 14B), 
indicating that FAK is critical for this aspect of PDGF-stimulated cytoskeletal 
remodeling. 
 
A considerable body of evidence indicates that FA
ing components of the Rac signaling pathway, such as Cas, PI3 kinase, and 
DOCK18035,71,72.  To explore this pathway in FAK-depleted SMCs, we first analyzed 
global Rac1 activation in response to PDGF by using a GST-PBD pulldown assay.  
Consistent with previous reports73,74, PDGF rapidly and robustly activated Rac1 within 
2.5 minutes, and activation began to subside at 10 minutes (Figure 16A).  Further, this 
activation was comparable in the presence and absence of FAK, indicating that FAK is 
dispensable for global activation of Rac1 in PDGF-treated SMCs.   
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A. C.
 B.
 
 
 
Figure 15.  Rac1/PI3 Kinase/AKT signaling is not perturbed by FAK depletion.  A.  Serum-starved
SMCs were treated with PDGF for the timepoints indicated, then lysed and rotated with 30 ug of GST-
PBD-conjugated sepharose beads for 30 minutes.  Rac1 immunoblot was performed for bead-bound
Rac (upper) 
h
and 3% input lysates (lower).  B.  Serum-starved SMCs were treated for the timepoints
indicated, t en scraped into sample buffer and electophoresed.  Immunoblot was performed fo r
pAKTSer47  and ERK1/2 (loading control).  C.  Infected SMCs were transfected with GFP-WAVE2,
starved, then treated with PDGF and imaged in real time.  Images shown represent 5 minutes post-
PDGF.   
3
 
 
Despite this similarity in global Rac1 activation, we analyzed two downstream 
targets of Rac1 to explore possible specific signaling defects that might not be detectable 
by GST pulldown assay.  PI3 kinase, which interacts directly with FAK, plays a critical 
role in cell polarization and directional chemotaxis in multiple cell types via its 
downstream target, AKT75-77.  To determine if this signaling pathway might be perturbed 
in the absence of FAK, we analyzed AKT phosphorylation in PDGF-treated SMC lysates.  
In LacZ- and Cre-infected SMCs, AKT was similarly phosphorylated following PDGF 
treatment (Figure 16B), suggesting that FAK depletion has no significant effect on PI3 
kinase-AKT signaling. 
As shown in Figure 13, we found that FAK was dispensable for dorsal ruffling, 
but required for cell polarization.  WAVE2, a member of the Wiskott - Aldrich Syndrome 
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Protein family, has been shown to be required for PDGF-induced polarization, but not 
dorsal ruffling78.  Further, this activity was shown to depend on PI3 kinase.  To determine 
if FAK might be required for WAVE2 activation, we used a GFP-tagged variant of 
WAVE2 to visualize localization of this protein in live SMCs.  In both LacZ- and Cre-
infected SMCs, WAVE2 was rapidly and robustly recruited to both dorsal and peripheral 
ruffling (Figure 16C), suggesting that FAK is not required for PDGF-induced WAVE2 
activation.  This finding is also consistent with the unperturbed PI3 kinase signaling 
shown in Figure 16B.             
 
Global activation of RhoA and myosin light chain. 
It has been suggested that FAK may regulate focal adhesion turnover by 
suppressing Rho activity33.  To assess RhoA activity in FAK-depleted SMCs, we used an 
approach similar to that described in Figure 16.  Interestingly, a GST pulldown assay 
indicated that RhoA was substantially activated by PDGF in SMC, in contrast to reports 
conducted in other cell types79-81 .  Like Rac1, RhoA was similarly activated in the 
presence and absence of FAK (Figure 17A).   Notably, basal RhoA activity prior to 
PDGF treatment was slightly elevated in the absence of FAK, consistent with 
observations of FAK-null fibroblasts14.  These data suggest not only that FAK is 
dispensable for global activation of RhoA in response to PDGF, but also that RhoA may 
play a unique role in PDGF signaling in vascular SMCs.   
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Contraction of the cell body is a critical component of polarization, and is in part 
mediated by the conventional myosin, myosin II82.  Myosin II, which consists of a light 
chain and a heavy chain, is activated by serine phosphorylation of the myosin light chain 
(MLC).  RhoA can promote MLC phosphorylation through its effector, Rho kinase 
(ROCK) by two principle mechanisms83.  First, ROCK can directly phosphorylate 
myosin light chain.  Second, it can inhibit the activity of myosin light chain phosphatase, 
thereby promoting the phosphorylated state of myosin light chain.  We assessed MLC 
phosphorylation in PDGF-treated SMCs to determine if impaired contractility might 
underlie the defective polarization of FAK-depleted cells.  PDGF induced modest 
phosphorylation of MLC, peaking at 30 minutes and subsiding by 60 minutes (Figure 
17B).  Interestingly, this phosphorylation was dramatically attenuated in FAK-depleted 
SMCs, despite comparable basal levels prior to treatment.  Thus, while RhoA activation  
A.
B.
Figure 16.  RhoA/myosin light chain signaling is perturbed by FAK depletion.  A.  Serum-starved
SMCs were treated with PDGF for the indicated timepoints, then lysed and rotated with 40 ug of GST-
RBD beads for 30 minutes.  Immunoblot was performed for bead-bound RhoA (upper) and 5% input
(lower).  Blot provided courtesy of Joan Taylor.  B.  Serum-starved SMCs were treated with PDGF for
the indicated timepoints, then lysed and immunoblotted for pMLCSer19 and ERK1/2 (loading control).  
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appears FAK-independent at the global level, this finding indicates perturbed signaling to 
a specific RhoA target.  
 
PDGF-induced localization of Dia2. 
The formin Dia2 has been well characterized in vitro as a promoter of unbranched 
actin.  However, the in vivo function of the DRFs is still poorly understood.  Further, the 
role of the DRFs in PDGF signaling has not been investigated.  We hypothesized that 
Dia2 might be important in SMC migration to PDGF, and assessed this by imaging live 
cells expressing YFP-tagged Dia2.  Surprisingly, PDGF treatment redistributed Dia2 
dramatically (Figure 18A, upper).  At baseline, Dia2 was diffusely distributed.  Following 
PDGF treatment, however, it was driven to prominent streaks at the periphery of the cell, 
the localization and appearance of which were consistent with those of mature focal 
adhesions.  Moreover, this localization pattern was absent in FAK-depleted SMCs 
(Figure 18A, lower).  To confirm that these structures were focal adhesions, we 
cotransfected SMCs with YFP-Dia2 and mCherry-paxillin, a known marker of focal 
adhesions.  Indeed, following PDGF treatment, the Dia2-containing streaks colocalized 
with mCherry paxillin, while immature focal contacts were highlighted by paxillin alone 
(Figure 18B).  Together, these observations indicate that FAK is required for localization 
of Dia2 to mature focal adhesions in response to PDGF.                     
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Figure 17.  PDGF drives Dia2 to focal adhesions only in the presence of FAK.  A, B.  SMCs were
transfected with YFP-Dia2 (A) or YFP-Dia2 and mCherry-paxillin (B), then starved, treated with
PDGF, and imaged in real time.  Images shown represent 35 minutes post-PDGF. 
A.
 
 
 
 
 
 
 
 
 
 
 
 B.B. 
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Stabilized microtubules in FAK-depleted SMCs.   
Since the above data show that Dia2 is highly responsive to PDGF, we next 
wondered what the specific biological role of Dia2 in SMC migration might be.  It was 
previously reported that overexpression of FRNK ablated stabilized microtubules in 
migrating fibroblasts, and that this defect could be rescued by overexpression of 
constitutively active Dia134. To determine whether FAK-Dia signaling might play a 
similar role in SMCs, we performed Western blot analysis and immunohistochemical 
staining of detyrosinated tubulin (glu-tubulin), a marker of stabilized microtubules.  By 
western blot, PDGF treatment had no significant effect on glu-tubulin levels in either 
LacZ- or Cre-infected cells (Figure 19A), consistent with previous reports in 
fibroblasts84.  Furthermore, glu-tubulin was abundant in both LacZ- and Cre-infected 
cells at baseline (Figure 19B), suggesting that the FAK-Dia signaling axis is not critical 
for microtubule stabilization in vascular SMCs. 
A. 
B.
Figure 18.  FAK-Dia
signaling is dispensable for
microtubule stabilization.
A. Densitometry of western
blot for glu-tubulin at various
timepoints post-PDGF was
calculated using NIH ImageJ.
Data shown represents the
average of three blots.  B.
Infected SMCs were serum-
starved, fixed in methanol,
then stained for glu-tubulin
and imaged at 40x mag.  
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A novel interaction between Dia2 and cortactin. 
 In addition to focal adhesion localization, we noted a second response of YFP-
Dia2 to PDGF treatment in live SMCs.  Namely, like cortactin and WAVE2, Dia2 
localized to areas of membrane ruffling in a robust manner (Figure 20A).  Further, GFP-
Dia2 and endogenous cortactin are both enriched at membrane ruffles in serum-
maintained SMCs, as demonstrated by immunocytochemistry (Figure 20B).  
Interestingly, unlike focal adhesion targeting, this localization pattern was FAK-
independent.  Given this observation, and a previous report implicating cortactin as a 
formin binding protein, we wondered whether Dia2 and cortactin might interact in SMCs.   
 
A. 
 
 
 
 
 
B.  
 
 
 
 
 
 
Figure 19.  GFP-Dia2 and cortactin are enriched at membrane ruffles.  A.  Infected SMCs were
transfected with GFP-Dia2, serum starved, and treated with 20 ng/mL PDGF.  Live cell images shown
represent 10 minutes after PDGF at 40x magnification.  B.   SMCs were transfected with GFP-Dia2
(green), then fixed and stained for endogenous cortactin (red).  Images shown are at 100x mag. 
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Initially, we hypothesized that the SH3 domain of cortactin would bind to the 
proline-rich region of the FH1 domain in Dia2, as suggested by a previous report85.  
However, using a GST pulldown assay, we found that the FH2 domain alone was capable 
of pulling down cortactin, indicating that the proline-rich FH1 domain was dispensable 
for this interaction (Figure 21A).  To ensure that Dia2 and cortactin were not simply 
interacting by virtue of their common association with F-actin, we repeated the pulldown 
in SMCs treated with latrunculin B, an inhibitor of actin polymerization.  Surprisingly, 
the interaction persisted in latrunculin-treated lysates, indicating that F-actin does not 
mediate the Dia2-cortactin interaction.  Moreover, Flag-Dia2 and GFP-cortactin 
associated strongly in COS lysates before and after latrunculin B treatment, as shown by 
coimmunoprecipitation (Figure 21B).  Taken together, these data suggest that the FH2 
domain of Dia2 binds to cortactin independently of F-actin.       
A. 
B. 
Figure 20.  Dia2 and cortactin associate independently of F-actin.  A.  SMCs received no treatment
or 0.5 uM latrunculin B for 1 hour.  For each reaction, 800 ug of lysate was incubated with 10 ug of
GST alone, GST-FH2, or GST-FH1FH2.  B.  COS-7 cells were cotransfected with Flag and GFP empty
vectors, or with Flag-Dia2 and GFP-cortactin.  Cells received no treatment or latrunculin B for 1 hour.
Triton.  For each reaction, 1 mg lysate was rotated with 35 uL of Flag-M2 agarose beads.  Input lanes
represent 20 ug for both A and B.   
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DISCUSSION 
 
Understanding the biological role of FAK: the importance of cell type.  
 Based on previous evidence, it is clear that FAK is critical for cell migration in 
various cellular and organismal systems.  However, it is also clear that the specific 
manner in which FAK mediates migration varies between cell types, as summarized in 
Table 2.  Additionally, several lines of evidence suggest that FAK might have a unique 
biological role in SMCs, as discussed previously.  Given this conceptual framework, we 
sought to perform the first conditional FAK knockout in differentiated SMCs.  While 
some overlap exists between the phenotype described in this work and those described in 
Table 2, our study highlights several aspects in which the biological role of FAK in 
SMCs differs from that described in other cell types.   
Cell Type Phenotypic Consequence of FAK Inhibition 
Fibroblasts 
Rounded morphology; more focal adhesions86; reduced focal 
adhesion turnover33; violent trailing edge release87; multiple 
leading edges30; reduced microtubule stability32 
Endothelial 
cells 
No membrane ruffles or lamellipodia; spiky peripheral actin 
protrusions; nonpolarized cell movement19 
Epithelial 
cells 
Inhibited actin/microtubule reorganization at leading edge; fewer 
focal adhesions88 
Keratinocytes Disorganized actin cytoskeleton; increased stability of focal adhesions and microtubules20 
Macrophages Elevated protrusive activity; reduced lamellipodial persistence; altered adhesion dynamics89 
 
Table 2.  Effects of FAK inhibition on migration of different cell types.  FAK inhibition can alter
focal adhesion turnover, microtubule stability, actin organization, and lamellipodia formation,
depending on cell type.   
 
 First, FAK depletion had no obvious effects on SMC growth.  This contrasts with 
studies conducted in melanoma cells90, fibroblasts91, and endothelial cells92, in which 
suppression of FAK signaling correlates with impaired cell proliferation.  Second, FAK 
depletion did not significantly impact apoptosis, in contrast to studies in epithelial 
cells93,94, fibroblasts95,  leukemic cells96, and glioblastoma cells97, which suggest both 
positive and negative regulatory roles for FAK in apoptosis.  Thirdly, I saw no obvious 
change in the size or number of focal adhesions in FAK-depleted SMCs, while studies in 
fibroblasts have shown that FAK depletion results in increased focal adhesion formation 
and decreased focal adhesion turnover33,86.  Additionally, FAK-depleted SMCs displayed 
no impairments in membrane ruffling, cell spreading, microtubule stability, or 
organization of the actin cytoskeleton, all of which have been described in fibroblasts and 
keratinocytes20.  Taken together, our findings underscore the importance of cell type as a 
determinant of FAK function, and support the concept of a SMC-specific role for FAK. 
 Above, I identified Dia2 and myosin light chain, both of which are activated by 
RhoA, as critical mediators of FAK-dependent SMC chemotaxis.  Additionally, I found 
that PDGF globally activates RhoA in SMCs, while it does not in other cell types.  These 
observations combine to implicate RhoA as a key mediator of FAK-dependent migration 
in differentiated SMCs.  This implication is of particular interest given evidence that Rho 
signaling is critical to the process of SMC differentiation98-101.  Moreover, it has recently 
been published that the RhoA-Dia2 signaling axis is of particular importance in activating 
transcription of SMC-specific genes44.  Given the special role of RhoA in determining 
SMC fate, one could hypothesize that it might also facilitate a unique FAK signaling 
pathway in migrating SMCs.  
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 Understanding FAK-dependent migration: variability in experimental systems. 
 Along with cell type, the mechanism by which FAK signaling is suppressed is 
important to consider when comparing studies of FAK-dependent migration.  In this 
study, we used the fakflox/flox  model to completely abrogate production of the active FAK 
protein.  This technique differs from pharmacological inhibition of FAK by agents such 
as PP2, overexpression of point mutations blocking FAK phosphorylation or protein-
protein interactions, or microinjection of interfering peptides or antibodies.  Importantly, 
it also differs from overexpression of FRNK, a commonly used method of FAK 
inhibition.  While FRNK undoubtedly acts as a dominant negative for FAK, it may also 
sequester various C-terminal binding partners for FAK, which likely impacts SMC 
biology differently than ablation of endogenous FAK.  The use of FRNK as a tool for 
FAK inhibition is further complicated by our poor understanding of the regulation and 
function of endogenous FRNK.   
Different methods of FAK inhibition could help explain discrepancies within the 
SMC literature.  For instance, we and others have shown that overexpression of FRNK 
suppresses not only migration to PDGF, but also PDGF-stimulated proliferation18.  
Further, it has been proposed that FRNK overexpression attenuates SMC migration to 
PDGF by downregulating ERK signaling15.  In contrast to this, I have found no changes 
in PDGF-stimulated growth or ERK activation following FAK ablation.  Our lab also 
reported that FRNK overexpression attenuates Rac activation in PDGF-treated SMCs16, 
while I have found Rac activation to be FAK-independent in the floxed-fak system.  
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Additionally, while most studies of FAK-dependent migration have focused on 
adhesion-driven haptotaxis, this study has focused solely on PDGF-stimulated 
chemotaxis.  Although these two processes share several basic mechanical processes (i.e., 
polarization, focal adhesion turnover, lamellipodial formation, etc), the molecular 
mechanisms by which these events are carried out can differ between extracellular 
stimuli.  Finally, adhesion-driven studies usually monitor cells maintained in serum-
containing media, which contains a host of soluble factors that regulate diverse signaling 
pathways.  As suggested in Figure 11, some of these factors can stimulate SMC 
chemotaxis independently of FAK.  Thus, inclusion of FBS can obfuscate the role of a 
specific molecular component in cell motility.  In this study, I used serum starvation to 
dampen FBS-induced signaling before applying PDGF to stimulate chemotaxis.  
 
FAK as a regulator of Rho-mediated cell contractility. 
 Above, I present evidence that a FAK-RhoA-ROCK signaling axis facilitates 
contraction of the cell body during SMC migration.  Consistent with previous 
reports102,103 I found that pharmacological inhibition of ROCK with compound Y-27632 
blocked PDGF-stimulated migration in a transwell assay (data not shown). Interestingly, 
inhibition of MEK, p38, or PI3 kinase, all of which have been implicated as critical to 
cell migration in various systems104, resulted in little to no impairment.  This suggests 
that ROCK is indeed a critical regulator of PDGF-driven SMC migration, and supports 
our claim that abrogated MLC activation could underlie impaired migration in FAK-
depleted cells.   
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The current literature presents varying concepts of the FAK-ROCK relationship, 
depicting FAK as both upstream and downstream of ROCK, and as both a positive and 
negative regulator of ROCK.  It was recently shown that impaired trailing edge retraction 
induced by FAK inhibition is rescued by overexpression of ROCK-activating 
constructs87.  It has also been reported that inhibition of ROCK attenuates FAK 
phosphorylation in migrating HeLa cells105, and that inhibition of FAK elevates ROCK 
activity in endothelial cells106.  ROCK inhibition has been shown to abrogate 
phosphorylation of FAK in neutrophils107 and cardiomyocytes exposed to cyclic 
stretch108.  Finally, Src and FAK were recently demonstrated to be necessary for MLC 
phosphorylation in ephrinA1-treated carcinoma cells109.   
While myosin activation is the best understood mechanism for generating 
contractile force, a growing body of evidence suggests that actin polymerization may 
play a distinct role in this biological process, specifically in SMCs110.  Thus, one can 
imagine that the Rho GTPases, which facilitate various modes of actin polymerization, 
might regulate SMC contractility in this second manner.  Indeed, it has been reported that 
contractile agonists stimulate RhoA-mediated actin polymerization in airway and cerebral 
artery SMCs111,112.   It has also been shown that pharmacological inhibition of actin 
polymerization results in a profound reduction in contractility, despite having no effect 
on myosin phosphorylation113.  While FAK-depleted SMCs display no global 
abnormalities in stress fiber organization or membrane protrusion, it is possible that a 
more subtle defect in actin remodeling could contribute to impaired contractility in these 
cells.  Such a scenario could involve spatiotemporally distinct activity of actin 
polymerizing factors, such as the diaphanous-related formins.  It is well documented that 
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contractile stimuli induce the recruitment of multiple factors, such as alpha-actinin, 
vinculin, and paxillin, to adhesion complexes at the SMC cortex110.  Here, it is thought, 
these proteins help reorganize actin-matrix connections, thereby creating a stable network 
for the transmission of force.   
Currently, the physiological role of the DRFs in SMCs is poorly understood, and 
their involvement in SMC contractility remains wholly unexplored.  Dia2 was recently 
shown to localize to focal adhesions at the leading edge of migrating epithelial cells, 
where it appears to regulate focal adhesion turnover by maintaining a stable pool of 
cortical actin114.  Others have proposed that Dia1 facilitates turnover by targeting 
microtubules to focal adhesions49.  However, in FAK-depleted cells we find that 
mislocalization of Dia2 is not associated with defective protrusion or disorganized 
microtubules, but rather a contractile impairment that likely contributes to a nonpolarized 
phenotype.  Given the emerging paradigm suggesting that actin polymerization is 
particularly relevant to SMC contractility, it is reasonable to hypothesize that localization 
of Dia2 to focal adhesions could mediate this process in SMCs.  Further experiments will 
be required to determine (a) if Dia2 does indeed mediate contractility by localizing to 
adhesion complexes; (b) the molecular mechanism by which it does so; and (c) how this 
pathway is regulated by FAK.   
Finally, it is worth noting that I detected aberrations in both ROCK and Dia2 
signaling, which are canonically understood as separate pathways, but found no change in 
global RhoA activity.  These findings may suggest that the ROCK and Dia2 pathways are 
not in fact separate, but influence each other.  Christopher Mack and colleagues have 
recently gathered evidence that ROCK directly phosphorylates Dia2, suggesting the 
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existence of molecular crosstalk between these two RhoA effectors (personal 
communication).  Similarly, while myosin activation and actin polymerization are 
currently understood as separate modes of contractile force generation, the possibility that 
ROCK-Dia2 crosstalk could unite these two physiological mechanisms merits further 
study.   
 
New roles for Dia2 in cytoskeletal remodeling. 
 Copious biochemical evidence has characterized the DRFs as promoters of 
unbranched actin polymerization.  However, the physiological activity of these proteins is 
not well understood.  In this work, I show that Dia2 localizes to focal adhesions 
dependently of FAK, and to membrane ruffles independently of FAK, and provide 
evidence of an interaction between Dia2 and cortactin.  To date, two other studies have 
shown interactions between Dia2 and Arp2/3 activators115,116.  Most recently, Dia2 was 
shown to bind directly to WAVE2 in complex with Arp2/3115.  Interestingly, a previous 
report conducted in mouse melanoma cells detected no interaction between Dia2 and 
WAVE116.  Instead, Dia2 bound to Abi1, another component of the 
WAVE/Abi1/Nap1/PIR121/HSP300 (WANP) complex, which activates Arp2/3.  The 
authors proposed that Abi1 targets Dia2 to the leading edge, where it participates in 
lamellipodial extension.  Notably, neither WAVE2 nor Abi1 interacted with the formin 
homology domains of Dia2, while my data suggest that cortactin interacts with the FH2 
domain.  Thus, while WAVE2, Abi1, and cortactin are all Arp2/3 activators, they appear 
to interact with Dia2 in different ways.  Further experiments are required to determine the 
specific region of cortactin that interacts with Dia2.   
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 This emerging body of data begs the question: if the only function of Dia2 is to 
polymerized unbranched actin filaments, why does it interact with proteins that promote 
branched actin polymerization?  Beli et al. propose that WAVE2 prevents filopodia 
formation by sequestering Dia2, and show that overexpression of WAVE2 mutants 
unable to bind Dia2 increases filopodia formation following EGF treatment.  Conversely, 
Yang et al. demonstrated a requirement for Dia2 in lamellipodia formation, and showed 
that Dia2 knockdown results in a disorganized dendritic actin network at the cell 
periphery, indicating that Dia2 is actively involved in the process of branched actin 
formation.  The authors propose that Dia2 may facilitate protrusion by creating stable 
“mother filaments” that form a platform for Arp2/3, and/or by protecting elongating 
filaments from capping.  They also present evidence that Dia2 participates in an 
alternative form of filipodial formation known as convergent extension.  In this process, 
Dia2 forms filipodia by bundling existing lamellipodial actin, rather than generating 
unbranched filaments de novo.  Clearly, the biochemical dogma of Dia2 function is being 
challenged by current in vivo studies.   
 At present, we have yet to explore the biological function of the Dia2-cortactin 
interaction.  I hypothesize that the two types of PDGF-induced Dia2 localization (i.e., 
membrane ruffles and focal adhesions) are mutually exclusive, and therefore it is possible 
that the Dia2-cortactin interaction must be disrupted for Dia2 to translocate to focal 
adhesions.  If this is true, then Dia2-cortactin binding might be enhanced in FAK-
depleted cells.  Further investigation is needed to determine the extracellular cues and 
signaling events that regulate Dia2-cortactin binding.  Additionally, electron microscopy 
could reveal if and how these two proteins polymerize actin differently when associated 
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with each other, and whether blockade of their interaction induces formation of aberrant 
actin structures.  Undoubtedly, the interaction I have identified in this work represents an 
exciting opportunity to further our limited understanding of Dia2 function in cell 
migration.                             
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APPENDIX: KNOCKDOWN OF LEUPAXIN IN VASCULAR SMCs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
ABSTRACT 
  
Members of the paxillin family of LIM domain-containing proteins are focal 
adhesion-targeted factors that play important roles in cytoskeletal remodeling and cell 
motility.  Leupaxin, a recently identified member of this family, has also been shown to 
regulate motility in hematopoetically derived cells.  Our lab previously reported that 
leupaxin is enriched in vascular SMCs, binds FAK, and may promote SMC 
differentiation by interacting with serum response factor (SRF) in the nucleus.  Here, we 
present siRNA-mediated knockdown of endogenous leupaxin in human aortic SMCs, and 
the effects of leupaxin depletion on SMC motility.  Transfection with an siRNA specific 
to leupaxin significantly diminished leupaxin levels after 72 hours, but had no effect on 
the expression or localization of paxillin or Hic-5.  Leupaxin-depleted cells were unable 
to migrate to serum-containing media in a three-dimensional transwell assay, and 
exhibited reduced cell speed and directional persistence in a two-dimensional context.  
Further, cortactin staining revealed ragged, spiky membrane ruffles at the periphery of 
leupaxin-depleted SMCs.  These preliminary findings point to an important role for 
leupaxin in SMC motility, and invite further investigation into the function of this protein 
during development.        
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INTRODUCTION 
  
Leupaxin, a tyrosine kinase substrate recently identified in leukocytes, is a 
member of the paxillin family of proteins117.  The C-terminus of leupaxin, which shares 
70% identity with paxillin, contains four 50-60 amino acid regions known as LIM 
domains.  LIM domains contain two zinc finger motifs, which are composed of 
conserved arrangements of cysteine, histidine, and aspartate residues.  LIM domains 
facilitate focal adhesion targeting of paxillin118,  and can interact with other LIM domains 
and tyrosine-containing motifs119.  The leupaxin C-terminus also possesses three LD 
motifs, which are named for their characteristic N-terminal leucine/aspartate pair.  In 
paxillin, LD motifs have been identified as binding sites for FAK and vinculin118,120, and 
FAK-LD binding has been linked with focal adhesion targeting of FAK118.  While the 
functions of leupaxin’s LIM domains remain unknown, the LD2 and LD3 motifs have 
been shown to interact with c-Src121 and Lyn122, respectively, and nuclear export 
sequences were recently identified in LD3 and LD4123.  
 To date, the leupaxin knowledgebase is extremely limited.  Table 3 summarizes 
the proposed binding partners and biological roles of leupaxin identified in the current 
literature.  While the majority of leupaxin studies have been conducted cells of 
hematopoetic origin, recent reports have detected leupaxin expression in metastatic 
prostate cancer cells121,123 and vascular SMCs124.  Like paxillin and Hic-5125,126, leupaxin 
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localizes to focal adhesions and appears to regulate cytoskeletal remodeling and cell 
motility.  In bone-derived prostate cancer cells, overexpression of leupaxin results in 
increased Rho GTPase activity and increased cell migration121, while siRNA-mediated 
knockdown inhibits cell invasion and motility123.  In osteoclasts, leupaxin overexpression 
enhances cell adhesion, induces a motile phenotype, and enhances resorption127, while 
knockdown inhibits resorption128, a process dependent on adhesion and assembly of 
actin-rich podosomes.  Leupaxin associates with several known regulators of the actin 
cytoskeleton, including the Arf GAP, p95 PKL128, further supporting a role for leupaxin 
in cell motility. 
  
Binding 
Partner Cell Type Putative Biological Function 
PYK2 
Macrophages117, 
osteoclasts128, prostate 
cancer cells121 
Focal adhesion adapter protein 
PTP-PEST Spleen
129, osteoclasts127, 
prostate cancer cells121 
Regulation of antigen receptor 
signaling; podosomal remodeling 
c-Src Osteoclasts
127, protstate 
cancer cells121 
Podosomal complex signaling, 
osteoclast activation 
p95 PKL Osteoclasts128 Podosomal remodeling 
FAK Vascular SMCs
124, 
osteoclasts128 
Podosomal complex signaling 
Lyn B-cell lymphoma
122 Regulation of B-cell receptor 
signaling 
SRF Vascular SMCs124 Promotion of SMC differentiation 
Table A1.  Identified binding partners of leupaxin, and putative biological functions of each
interaction.  Mounting evidence implicates leupaxin as an important mediator of adhesion,
migration, and invasion.   
 
 
Our lab recently reported that leupaxin interacts with FAK in vascular SMCs, and 
may promote SMC differentiation124.  Overexpression of leupaxin enhanced transcription 
of SMC-specific genes, and this activity was attributed to a leupaxin-SRF interaction 
within the nucleus.  This study provides evidence of an important role for leupaxin in 
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SMC biology, and lends further credence to the proposed connection between 
cytoskeletal remodeling and SMC differentiation.    
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EXPERIMENTAL PROCEDURES 
 
Cell Culture.  Primary human aortic SMCs, culture media, and supplements were 
all purchased from Clonetics.  Cells were cultured in SmBM smooth muscle basal 
medium, supplemented with the SmGM-2 bullet kit (amphotericin/gentamicin, 
recombinant human insulin, recombinant human epidermal growth factor, human 
fibroblast growth factor-B, and 5% fetal bovine serum).  At the time of purchase, cells 
had been passaged six times, and were not used beyond 7 additional passes following 
purchase.   
siRNA Design and Transfection.  BLOCK-iT standard siRNA oligos were 
designed and purchased through Invitrogen.  Oligos were targeted to the 3’ untranslated 
region of Homo sapiens leupaxin mRNA (accession number NM_004811), at nucleotide 
position 1732 (GCAUCUUCCUUCAGUGUAU). Non-targeted control sequence was the 
Dharmacon siControl Non-targeting siRNA #1 (UGGUUUACAUGUCGACUAA).  
Oligos were transfected into SMC using Dharmafect-1 reagent (Dharmacon) according to 
manufacturer’s instructions.  Experiments were performed 72 hours following siRNA 
transfection.   
Antibodies.  The monoclonal antibody to human leupaxin was a generous gift 
from Dr. Don Staunton of the ICOS Corporation, Bothell, Washington State.  The 
antibodies to paxillin and Hic-5 were purchased from Transduction Laboratories.  All 
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three antibodies were used at a dilution of 1:1000 for western blot and 1:500 for 
immunohistochemistry.  Anti-cortactin was purchased from Upstate and used at a dilution 
of 1:500 for immunohistochemistry.  The antibody to total C-terminal ERK 1/2 was 
purchased from Upstate and used at 1:1000 for western blot.   
Immunofluorescent Staining.  Human aortic SMCs were plated onto LabTek II 
chamber slides (Nunc) and transfected with siRNA the following day.  72 hours after 
transfection, chamber slides were fixed in 4% paraformaldehyde for 20 minutes at room 
temperature.  Slides were blocked in 20% goat serum and 3% BSA in 1X PBS for 30 
minutes at RT, then incubated in primary antibody for 1 hour at RT and washed thrice in 
1X PBS for 4 minutes each.  Slides were incubated with FITC-phalloidin (Molecular 
Probes) at a dilution of 1:500 and Texas Red-anti-mouse IgG (Jackson Immunoresearch) 
at 1:1000 in 1X PBS for 1 hour at RT, then washed thrice with PBS for 4 minutes each.  
Following a final aqueous rinse, slides were mounted and coverslipped.   
Transwell Assays.  Human aortic SMCs were transfected with nontargeted 
control or siRNA or anti-leupaxin siRNA.  72 hours after transfection, cells were plated 
onto BD Biocoat transwell inserts (8 micron pore size) coated with 20 ug/mL fibronectin 
(Sigma) at a density of 15K/insert.   Fetal bovine serum was added to the bottom well, 
and cells were allowed to chemotax overnight (approximately 16 hours).  Transwells 
were fixed in 4% paraformaldehyde for 20 minutes at RT, rinsed thrice, then stained for 1 
hour in 1% crystal violet at RT.  Insert tops were scraped with a cotton swab and rinsed 
with 1X PBS three times, and migrated cells were counted at 10x magnification over 4 
fields in 3 separate wells.     
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Microscopy and Live Cell Imaging.    Immunofluorescence images were acquired 
using an Olympus BX51 upright microscope equipped with a 40x oil immersion lens and 
a Affymetrix CoolSnap CCD camera.  Images were processed using Adobe Photoshop.  
For random motility assays, cells were imaged using an Olympus IX70 inverted 
microscope encased in a Plexiglas housing and the internal environment was kept at a 
temperature of 34.5º C and a relative humidity of 60%.  Dishes were perfused with 100% 
CO2 at a flow rate sufficient to maintain optimal pH.  Tracking images were acquired at 
4x magnification every 5 minutes by an Optronix DEI 750 CCD camera using OpenLab 
software (Improvision).  Tracking measurements and motion path images were generated 
using the MultiTracker plugin for NIH ImageJ.   
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PRELIMINARY RESULTS 
Knockdown of endogenous leupaxin in human aortic SMCs. 
 Given our recent finding that leupaxin is enriched in vascular SMCs124, we 
transfected human aortic SMC with an siRNA oligo targeted to the human leupaxin gene 
to observe the effects of leupaxin silencing on SMC biology. Transfection with a 
leupaxin-targeted siRNA abrogated leupaxin expression, but had no effect on expression 
or localization of paxillin or Hic-5 (Figure A1).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1.  Knockdown of
leupaxin in human aortic SMCs.
Left: Fluorescent staining using
monoclonal antibodies to leupaxin,
Hic-5, or paxillin, were labeled with
Texas Red anti-mouse IgG (red) and
FITC-phalloidin (green).  Images
shown are at 40x magnification.
Right: Western blot showing total
expression of paxillin family
members in SMCs transfected with
a nontargeted control siRNA or
leupaxin-specific siRNA.     
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By eye, leupaxin knockdown cells demonstrated no rounding, apoptosis, or loss of 
adhesion as described in other reports, but were noticeably sparser and consistently 
yielded less total protein than control-transfected SMCs.  While we have not performed 
quantitative assays to confirm this effect, this preliminary observation could suggest that 
leupaxin knockdown induces growth arrest in SMCs.  Because we recently showed that 
leupaxin overexpression upregulates SMC gene expression, we expected that SM marker 
genes might be downregulated in leupaxin-silenced cells.  However, western blotting for 
SM22 and smooth muscle alpha-actin yielded inconclusive results, possibly due to 
passage-specific effects on SMC biology.  Thus, it remains unclear whether leupaxin 
regulates SMC differentiation in its endogenous state.               
 
Impaired motility in leupaxin-depleted SMCs. 
 The paxillin family members are known regulators of cytoskeletal dynamics, due 
to their status as focal adhesion adapter proteins130.  Enhanced or diminished leupaxin 
expression has been shown to correlate with increased or decreased cell motility, 
respectively.  We used a transwell assay to assess the impact of leupaxin silencing on 
SMC motility.  Remarkably, leupaxin-depleted cells were unable to migrate to serum-
containing media, indicating a gross defect in three-dimensional migration that is not 
specific to a certain agonist (Figure A2.A).   
To determine whether this impairment was evident in a two-dimensional context, 
we used live cell imaging to visualize SMC motility in the presence and absence of 
leupaxin.  In a wound healing assay, both control and leupaxin knockdown SMCs closed 
a scratch wound completely by 16 hours (Figure A2.B), indicating that some directed  
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B. A. 
Figure A2.  Three-dimensional mi
 
 
 
 
 
 
 
 
 
 
gration, but not wound healing, is abrogated by
leupaxin knockdown.  A: Human aortic SMCs were transfected with nontargeted control or
leup in-specific siRNA, then plated onto fibronectin-coated transwell inserts and alloweax
 
d
to m e to 10% FBS overnight.  Migrated cells were fixed, stained, and counted in
triplicate.  B: Cells were transfected as above, then plated on uncoated tissue culture dishes
in serum-containing media and wounded with a pipet tip.  
igrat
 
 
two-dimensional movement is possible in the absence of leupaxin.  However, when cells 
were sparsely plated, cell tracking revealed that the paths of leupaxin-depleted cells were 
visibly circuitous in nature and were less persistent than those of control cells (Figure 
A3.A).  Quantitatively, knockdown cells exhibited slower cell speed by approximately 
35%, and net displacement from their point of origin was reduced by about 55% (Figure 
A3).  Thus, in sparsely plated cells, leupaxin silencing appears to result in disoriented 
two-dimensional SMC motility.       
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A. 
B. 
Figure A3.  Disoriented two-dimensional motility in sparsely plated leupaxin knockdown
cells.  A,B. SMCs were transfected with control or leupaxin-specific oligos for 72 hours, then
trypsinized and replated at equal densities on uncoated tissue culture dishes in serum-
containing media.  Cells were imaged every 5 minutes over a span of 8 hours.  Tracking
measurements and cell paths were generated using the ImageJ MultiTracker plugin. A.  Each
colored line represents the path of a single cell over 8 hours. 
 
Malformed membrane ruffles in leupaxin-depleted SMCs.   
 In light of this motility defect, we used immunofluorescent staining to visualize 
cytoskeletal organization and remodeling in leupaxin knockdown cells.  Basally, no 
aberrations were evident in stress fiber organization, and there were no obvious 
differences in cell shape or size.  However, cortactin staining, which highlights 
membrane ruffles, revealed malformed membrane ruffling in leupaxin knockdown cells 
stimulated with PDGF (Figure A4).  In contrast to the smooth, continuous cortactin 
staining shown by control cells, leupaxin-depleted SMCs exhibited ragged, disconnected 
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staining at the cell periphery, suggesting that leupaxin is required for proper lamellipodial 
formation.  Interestingly, knockdown cells were still capable of forming dorsal ruffles, 
indicating that the machinery responsible for driving branched actin polymerization is 
activated to some degree in the absence of leupaxin.  Preliminary kymographic analysis 
showed that protrusions of leupaxin-depleted cells extended at a slower rate and for a 
shorter duration than control cells.  These findings suggest that depletion of leupaxin 
results in malformed, unstable lamellipodia, which likely contribute to the dramatic 
motility defect displayed by these cells.      
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4.  Malformed membrane ruffles in PDGF-treated leupaxin knockdown cells.
Human aortic SMCs were transfected with nontargeted control or leupaxin-specific siRNA
oligos for 72 hours, then serum starved for 16 hours and treated with 20 ng/mL PDGF for 5
minutes.  Cells were fixed and stained for cortactin (red) and phalloidin (green), then imaged at
40x magnification.   
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CONCLUSIONS AND FUTURE DIRECTIONS 
  
The study of leupaxin is still in its infancy, yet the existing body of literature 
provides convincing evidence that this protein plays an important role in cell motility.  
Here, we have conducted the first SMC-specific knockdown of leupaxin, and collected 
preliminary data that implicates it as critical for migration in this cell type.  It is 
interesting to note that the migrational phenotype of leupaxin-depleted SMCs is even 
more severe than that of FAK-depleted SMCs, described in the main body of this work.  
While FAK appears necessary for PDGF-specific SMC migration, leupaxin is critical for 
migration to serum-containing media, which contains a vast array of chemotactic signals.  
Also in contrast to FAK-depleted cells, leupaxin knockdown cells display a clear defect 
in lamellipodial formation.  Thus, it is reasonable to hypothesize that leupaxin may play a 
broader role than FAK, and regulate some of the basic cytoskeletal machinery required 
for general SMC motility.  Additionally, preliminary observations strongly suggest that 
leupaxin depletion arrests SMC growth.  Taken together, the experiments we have 
conducted thus far suggest that leupaxin plays an important role in several aspects of 
SMC biology and clearly merits further study in this cell type. 
 The motility experiments conducted here highlight an important consideration in 
the field of cell migration: mechanistic differences between three-dimensional and two-
dimensional systems.  Scratch wound assays indicate that leupaxin is not required for 
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SMCs to migrate into a wound, yet transwell assays reveal a dramatic inability of 
knockdown cells to chemotax towards serum-containing media.  This could suggest a 
special function for leupaxin in three-dimensional invasion, a concept that is supported 
by the critical role of this protein in osteoclastal podosome formation and resorption.  It is 
well documented that distinct molecular and biomechanical events, such as matrix 
metalloprotease secretion and invadopodia formation, are involved in 3D migration131.  
Furthermore, it has been reported that focal adhesions are constructed and organized 
differently on 3D matrices than 2D substratum132.  This could be especially relevant to 
the function of leupaxin, given its localization to focal adhesions.        
 Our lab recently published that overexpressed leupaxin undergoes 
nuclear/cytoplasmic shuttling in SMCs, and promotes SMC marker gene expression via 
direct interaction with SRF.  Concurrently, others reported a similar phenomenon in 
prostate cancer cells, where overexpressed leupaxin activates transcription of the 
androgen receptor, purportedly regulating cancer cell apoptosis and invasion123.  Thus far, 
we have been unable to obtain consistent readouts of SMC marker gene expression 
following endogenous leupaxin knockdown (data not shown).  In human aortic SMCs, 
which are derived from the neural crest, leupaxin knockdown cells have shown 
unchanged or increased SMC marker gene expression.  In human coronary SMCs, which 
are derived from the proepicardial organ, knockdown cells have shown unchanged or 
decreased marker gene expression.  Interestingly, we have also seen changes in basal 
leupaxin expression levels from passage to passage.  These findings suggest that the role 
of leupaxin in SMC differentiation may depend on cell passage as well as SMC lineage, 
and invite in vivo assessment of leupaxin expression during embryonic development.  
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Using an animal model, one could determine if leupaxin is differentially expressed in 
distinct cell lineages, and/or at specific stages of SMC differentiation.  Obviously, it is 
also important to consider differences between endogenous protein manipulation and 
protein overexpression as contributors to our conflicting results.  Lastly, quantitative real 
time RT-PCR may provide a more sensitive and reliable tool for SMC marker gene 
analysis in leupaxin knockdown cells.   
 Given the clinical relevance of SMC proliferation and invasion to atherosclerosis 
and restenosis, it is exciting to consider leupaxin, which appears to regulate both of these 
biological processes in vitro, as a potential therapeutic target.  In addition to revealing the 
role of leupaxin during vasculogenesis, in vivo studies could elucidate the significance of 
this protein in the initiation and progression of vascular disease.  In my opinion, it will be 
important to continue human SMC experimentation in tandem with small mammal 
studies. While a human SMC system is more technically limiting than a murine system, it 
also helps provide evidence for the relevance of leupaxin in the human vasculature.  We 
have previously shown that leupaxin is expressed in human vascular SMCs in vivo as 
well as in vitro.  Others have recently reported that leupaxin is overexpressed in invasive 
human prostatic cancers.  Future analysis of human tissue samples could determine if 
leupaxin is similarly upregulated in vascular disease states.  
 60
REFERENCES 
1. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A. & Betsholtz, C. Role of 
PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and 
pericytes during embryonic blood vessel formation in the mouse. Development 
126, 3047-55 (1999). 
2. Leveen, P. et al. Mice deficient for PDGF B show renal, cardiovascular, and 
hematological abnormalities. Genes Dev 8, 1875-87 (1994). 
3. Lindahl, P., Johansson, B.R., Leveen, P. & Betsholtz, C. Pericyte loss and 
microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-5 (1997). 
4. Berk, B.C. Vascular smooth muscle growth: autocrine growth mechanisms. 
Physiol Rev 81, 999-1030 (2001). 
5. Parsons, J.T. Focal adhesion kinase: the first ten years. J Cell Sci 116, 1409-16 
(2003). 
6. Schaller, M.D. et al. Autophosphorylation of the focal adhesion kinase, 
pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14, 1680-8 
(1994). 
7. Mitra, S.K., Hanson, D.A. & Schlaepfer, D.D. Focal adhesion kinase: in 
command and control of cell motility. Nat Rev Mol Cell Biol 6, 56-68 (2005). 
8. Schaller, M.D. et al. pp125FAK a structurally distinctive protein-tyrosine kinase 
associated with focal adhesions. Proc Natl Acad Sci U S A 89, 5192-6 (1992). 
9. Parsons, J.T., Martin, K.H., Slack, J.K., Taylor, J.M. & Weed, S.A. Focal 
adhesion kinase: a regulator of focal adhesion dynamics and cell movement. 
Oncogene 19, 5606-13 (2000). 
10. Kornberg, L., Earp, H.S., Parsons, J.T., Schaller, M. & Juliano, R.L. Cell 
adhesion or integrin clustering increases phosphorylation of a focal adhesion-
associated tyrosine kinase. J Biol Chem 267, 23439-42 (1992). 
11. Polte, T.R., Naftilan, A.J. & Hanks, S.K. Focal adhesion kinase is abundant in 
developing blood vessels and elevation of its phosphotyrosine content in vascular 
smooth muscle cells is a rapid response to angiotensin II. J Cell Biochem 55, 106-
19 (1994). 
12. Schaller, M.D. The focal adhesion kinase. J Endocrinol 150, 1-7 (1996). 
13. Furuta, Y. et al. Mesodermal defect in late phase of gastrulation by a targeted 
mutation of focal adhesion kinase, FAK. Oncogene 11, 1989-95 (1995). 
14. Ilic, D. et al. Reduced cell motility and enhanced focal adhesion contact formation 
in cells from FAK-deficient mice. Nature 377, 539-44 (1995). 
15. Hauck, C.R., Hsia, D.A. & Schlaepfer, D.D. Focal adhesion kinase facilitates 
platelet-derived growth factor-BB-stimulated ERK2 activation required for 
chemotaxis migration of vascular smooth muscle cells. J Biol Chem 275, 41092-9 
(2000). 
16. Sundberg, L.J., Galante, L.M., Bill, H.M., Mack, C.P. & Taylor, J.M. An 
endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not 
Ras/ERK-dependent signaling in vascular smooth muscle cells. J Biol Chem 278, 
29783-91 (2003). 
17. Tang, D.D. & Gunst, S.J. Depletion of focal adhesion kinase by antisense 
depresses contractile activation of smooth muscle. Am J Physiol Cell Physiol 280, 
C874-83 (2001). 
18. Taylor, J.M. et al. Selective expression of an endogenous inhibitor of FAK 
regulates proliferation and migration of vascular smooth muscle cells. Mol Cell 
Biol 21, 1565-72 (2001). 
19. Braren, R. et al. Endothelial FAK is essential for vascular network stability, cell 
survival, and lamellipodial formation. J Cell Biol 172, 151-62 (2006). 
20. Schober, M. et al. Focal adhesion kinase modulates tension signaling to control 
actin and focal adhesion dynamics. J Cell Biol 176, 667-80 (2007). 
21. Ivankovic-Dikic, I., Gronroos, E., Blaukat, A., Barth, B.U. & Dikic, I. Pyk2 and 
FAK regulate neurite outgrowth induced by growth factors and integrins. Nat Cell 
Biol 2, 574-81 (2000). 
22. Natarajan, M. et al. HEF1 is a necessary and specific downstream effector of FAK 
that promotes the migration of glioblastoma cells. Oncogene 25, 1721-32 (2006). 
23. Sieg, D.J. et al. FAK integrates growth-factor and integrin signals to promote cell 
migration. Nat Cell Biol 2, 249-56 (2000). 
24. Corley, K.M., Taylor, C.J. & Lilly, B. Hypoxia-inducible factor 1alpha modulates 
adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells. J 
Cell Biochem 96, 971-85 (2005). 
25. Varadarajulu, J., Laser, M., Hupp, M., Wu, R. & Hauck, C.R. Targeting of 
alpha(v) integrins interferes with FAK activation and smooth muscle cell 
migration and invasion. Biochem Biophys Res Commun 331, 404-12 (2005). 
26. Kallergi, G., Mavroudis, D., Georgoulias, V. & Stournaras, C. Phosphorylation of 
FAK, PI-3K, and Impaired Actin Organization in CK-positive Micrometastatic 
Breast Cancer Cells. Mol Med 13, 79-88 (2007). 
 62
27. Hiscox, S., Jordan, N.J., Morgan, L., Green, T.P. & Nicholson, R.I. Src kinase 
promotes adhesion-independent activation of FAK and enhances cellular 
migration in tamoxifen-resistant breast cancer cells. Clin Exp Metastasis 24, 157-
67 (2007). 
28. Wu, C.S., Lan, C.C., Chiou, M.H. & Yu, H.S. Basic fibroblast growth factor 
promotes melanocyte migration via increased expression of p125(FAK) on 
melanocytes. Acta Derm Venereol 86, 498-502 (2006). 
29. Ridley, A.J. et al. Cell migration: integrating signals from front to back. Science 
302, 1704-9 (2003). 
30. Tilghman, R.W. et al. Focal adhesion kinase is required for the spatial 
organization of the leading edge in migrating cells. J Cell Sci 118, 2613-23 
(2005). 
31. Liu, G. et al. Netrin requires focal adhesion kinase and Src family kinases for 
axon outgrowth and attraction. Nat Neurosci 7, 1222-32 (2004). 
32. Palazzo, A.F., Eng, C.H., Schlaepfer, D.D., Marcantonio, E.E. & Gundersen, G.G. 
Localized stabilization of microtubules by integrin- and FAK-facilitated Rho 
signaling. Science 303, 836-9 (2004). 
33. Ren, X.D. et al. Focal adhesion kinase suppresses Rho activity to promote focal 
adhesion turnover. J Cell Sci 113 (Pt 20), 3673-8 (2000). 
34. Ezratty, E.J., Partridge, M.A. & Gundersen, G.G. Microtubule-induced focal 
adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat Cell 
Biol 7, 581-90 (2005). 
35. Hsia, D.A. et al. Differential regulation of cell motility and invasion by FAK. J 
Cell Biol 160, 753-67 (2003). 
36. Yano, H. et al. Roles played by a subset of integrin signaling molecules in 
cadherin-based cell-cell adhesion. J Cell Biol 166, 283-95 (2004). 
37. Humphrey, D. et al. In situ photoactivation of a caged phosphotyrosine peptide 
derived from focal adhesion kinase temporarily halts lamellar extension of single 
migrating tumor cells. J Biol Chem 280, 22091-101 (2005). 
38. Lauffenburger, D.A. & Horwitz, A.F. Cell migration: a physically integrated 
molecular process. Cell 84, 359-69 (1996). 
39. Pollard, T.D. Regulation of actin filament assembly by Arp2/3 complex and 
formins. Annu Rev Biophys Biomol Struct 36, 451-77 (2007). 
40. Buccione, R., Orth, J.D. & McNiven, M.A. Foot and mouth: podosomes, 
invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 5, 647-57 (2004). 
 63
41. Bishop, A.L. & Hall, A. Rho GTPases and their effector proteins. Biochem J 348 
Pt 2, 241-55 (2000). 
42. Goode, B.L. & Eck, M.J. Mechanism and Function of Formins in Control of 
Actin Assembly. Annu Rev Biochem (2007). 
43. Li, F. & Higgs, H.N. Dissecting requirements for auto-inhibition of actin 
nucleation by the formin, mDia1. J Biol Chem 280, 6986-92 (2005). 
44. Staus, D.P., Blaker, A.L., Taylor, J.M. & Mack, C.P. Diaphanous 1 and 2 regulate 
smooth muscle cell differentiation by activating the myocardin-related 
transcription factors. Arterioscler Thromb Vasc Biol 27, 478-86 (2007). 
45. Peng, J., Wallar, B.J., Flanders, A., Swiatek, P.J. & Alberts, A.S. Disruption of 
the Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for Drf3 
as an effector for Cdc42. Curr Biol 13, 534-45 (2003). 
46. Pellegrin, S. & Mellor, H. The Rho family GTPase Rif induces filopodia through 
mDia2. Curr Biol 15, 129-33 (2005). 
47. Nakano, K. et al. Distinct actions and cooperative roles of ROCK and mDia in 
Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-
Darby canine kidney cells. Mol Biol Cell 10, 2481-91 (1999). 
48. Riveline, D. et al. Focal contacts as mechanosensors: externally applied local 
mechanical force induces growth of focal contacts by an mDia1-dependent and 
ROCK-independent mechanism. J Cell Biol 153, 1175-86 (2001). 
49. Bershadsky, A.D. et al. Assembly and mechanosensory function of focal 
adhesions: experiments and models. Eur J Cell Biol 85, 165-73 (2006). 
50. Bershadsky, A.D., Balaban, N.Q. & Geiger, B. Adhesion-dependent cell 
mechanosensitivity. Annu Rev Cell Dev Biol 19, 677-95 (2003). 
51. Yamana, N. et al. The Rho-mDia1 pathway regulates cell polarity and focal 
adhesion turnover in migrating cells through mobilizing Apc and c-Src. Mol Cell 
Biol 26, 6844-58 (2006). 
52. Brunton, V.G. et al. Identification of Src-specific phosphorylation site on focal 
adhesion kinase: dissection of the role of Src SH2 and catalytic functions and 
their consequences for tumor cell behavior. Cancer Res 65, 1335-42 (2005). 
53. Westhoff, M.A., Serrels, B., Fincham, V.J., Frame, M.C. & Carragher, N.O. SRC-
mediated phosphorylation of focal adhesion kinase couples actin and adhesion 
dynamics to survival signaling. Mol Cell Biol 24, 8113-33 (2004). 
 64
54. Morishita, R. et al. Expression of smooth muscle cell-specific proteins in neural 
progenitor cells induced by agonists of G protein-coupled receptors and 
transforming growth factor-beta. J Neurochem 101, 1031-40 (2007). 
55. Uruno, T. et al. Activation of Arp2/3 complex-mediated actin polymerization by 
cortactin. Nat Cell Biol 3, 259-66 (2001). 
56. Weaver, A.M. et al. Cortactin promotes and stabilizes Arp2/3-induced actin 
filament network formation. Curr Biol 11, 370-4 (2001). 
57. Wu, H., Reynolds, A.B., Kanner, S.B., Vines, R.R. & Parsons, J.T. Identification 
and characterization of a novel cytoskeleton-associated pp60src substrate. Mol 
Cell Biol 11, 5113-24 (1991). 
58. Wu, H. & Parsons, J.T. Cortactin, an 80/85-kilodalton pp60src substrate, is a 
filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 120, 
1417-26 (1993). 
59. Tehrani, S., Tomasevic, N., Weed, S., Sakowicz, R. & Cooper, J.A. Src 
phosphorylation of cortactin enhances actin assembly. Proc Natl Acad Sci U S A 
104, 11933-8 (2007). 
60. Boyle, S.N., Michaud, G.A., Schweitzer, B., Predki, P.F. & Koleske, A.J. A 
critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced 
dorsal-wave formation. Curr Biol 17, 445-51 (2007). 
61. Head, J.A. et al. Cortactin tyrosine phosphorylation requires Rac1 activity and 
association with the cortical actin cytoskeleton. Mol Biol Cell 14, 3216-29 (2003). 
62. Weed, S.A., Du, Y. & Parsons, J.T. Translocation of cortactin to the cell 
periphery is mediated by the small GTPase Rac1. J Cell Sci 111 (Pt 16), 2433-43 
(1998). 
63. Bryce, N.S. et al. Cortactin promotes cell motility by enhancing lamellipodial 
persistence. Curr Biol 15, 1276-85 (2005). 
64. Huang, C., Liu, J., Haudenschild, C.C. & Zhan, X. The role of tyrosine 
phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem 
273, 25770-6 (1998). 
65. Patel, A.S., Schechter, G.L., Wasilenko, W.J. & Somers, K.D. Overexpression of 
EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion 
in vitro. Oncogene 16, 3227-32 (1998). 
66. Vuori, K. & Ruoslahti, E. Tyrosine phosphorylation of p130Cas and cortactin 
accompanies integrin-mediated cell adhesion to extracellular matrix. J Biol Chem 
270, 22259-62 (1995). 
 65
67. van Rossum, A.G., Moolenaar, W.H. & Schuuring, E. Cortactin affects cell 
migration by regulating intercellular adhesion and cell spreading. Exp Cell Res 
312, 1658-70 (2006). 
68. Agerer, F. et al. Cellular invasion by Staphylococcus aureus reveals a functional 
link between focal adhesion kinase and cortactin in integrin-mediated 
internalisation. J Cell Sci 118, 2189-200 (2005). 
69. Clowes, A.W., Reidy, M.A. & Clowes, M.M. Kinetics of cellular proliferation 
after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab 
Invest 49, 327-33 (1983). 
70. Beggs, H.E. et al. FAK deficiency in cells contributing to the basal lamina results 
in cortical abnormalities resembling congenital muscular dystrophies. Neuron 40, 
501-14 (2003). 
71. Cary, L.A., Han, D.C., Polte, T.R., Hanks, S.K. & Guan, J.L. Identification of 
p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J Cell 
Biol 140, 211-21 (1998). 
72. Armulik, A., Velling, T. & Johansson, S. The integrin beta1 subunit 
transmembrane domain regulates phosphatidylinositol 3-kinase-dependent 
tyrosine phosphorylation of Crk-associated substrate. Mol Biol Cell 15, 2558-67 
(2004). 
73. Hobson, J.P. et al. Role of the sphingosine-1-phosphate receptor EDG-1 in 
PDGF-induced cell motility. Science 291, 1800-3 (2001). 
74. Mackay, D.J. & Hall, A. Rho GTPases. J Biol Chem 273, 20685-8 (1998). 
75. Nukada, Y. et al. AILIM/ICOS-mediated elongation of activated T cells is 
regulated by both the PI3-kinase/Akt and Rho family cascade. Int Immunol 18, 
1815-24 (2006). 
76. Yoshimura, T., Arimura, N. & Kaibuchi, K. Signaling networks in neuronal 
polarization. J Neurosci 26, 10626-30 (2006). 
77. Servant, G. et al. Polarization of chemoattractant receptor signaling during 
neutrophil chemotaxis. Science 287, 1037-40 (2000). 
78. Suetsugu, S., Yamazaki, D., Kurisu, S. & Takenawa, T. Differential roles of 
WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell 
migration. Dev Cell 5, 595-609 (2003). 
79. Pertz, O., Hodgson, L., Klemke, R.L. & Hahn, K.M. Spatiotemporal dynamics of 
RhoA activity in migrating cells. Nature 440, 1069-72 (2006). 
 66
80. Sander, E.E., ten Klooster, J.P., van Delft, S., van der Kammen, R.A. & Collard, 
J.G. Rac downregulates Rho activity: reciprocal balance between both GTPases 
determines cellular morphology and migratory behavior. J Cell Biol 147, 1009-22 
(1999). 
81. Jimenez, C. et al. Role of the PI3K regulatory subunit in the control of actin 
organization and cell migration. J Cell Biol 151, 249-62 (2000). 
82. Schwartz, M.A. & Horwitz, A.R. Integrating adhesion, protrusion, and 
contraction during cell migration. Cell 125, 1223-5 (2006). 
83. Gerthoffer, W.T. Mechanisms of vascular smooth muscle cell migration. Circ Res 
100, 607-21 (2007). 
84. Gundersen, G.G., Kim, I. & Chapin, C.J. Induction of stable microtubules in 3T3 
fibroblasts by TGF-beta and serum. J Cell Sci 107 (Pt 3), 645-59 (1994). 
85. Chan, D.C., Bedford, M.T. & Leder, P. Formin binding proteins bear WWP/WW 
domains that bind proline-rich peptides and functionally resemble SH3 domains. 
Embo J 15, 1045-54 (1996). 
86. Sieg, D.J., Hauck, C.R. & Schlaepfer, D.D. Required role of focal adhesion kinase 
(FAK) for integrin-stimulated cell migration. J Cell Sci 112 (Pt 16), 2677-91 
(1999). 
87. Iwanicki, M.P. et al. FAK, PDZ-RhoGEF and ROCKII cooperate to regulate 
adhesion movement and trailing-edge retraction in fibroblasts. J Cell Sci 121, 
895-905 (2008). 
88. Jiang, X., Jacamo, R., Zhukova, E., Sinnett-Smith, J. & Rozengurt, E. RNA 
interference reveals a differential role of FAK and Pyk2 in cell migration, leading 
edge formation and increase in focal adhesions induced by LPA in intestinal 
epithelial cells. J Cell Physiol 207, 816-28 (2006). 
89. Owen, K.A. et al. Regulation of lamellipodial persistence, adhesion turnover, and 
motility in macrophages by focal adhesion kinase. J Cell Biol 179, 1275-87 
(2007). 
90. Kaneda, T. et al. Mutation of Y925F in focal adhesion kinase (FAK) suppresses 
melanoma cell proliferation and metastasis. Cancer Lett 270, 354-61 (2008). 
91. Lim, S.T. et al. Nuclear FAK promotes cell proliferation and survival through 
FERM-enhanced p53 degradation. Mol Cell 29, 9-22 (2008). 
92. Gilmore, A.P. & Romer, L.H. Inhibition of focal adhesion kinase (FAK) signaling 
in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7, 1209-
24 (1996). 
 67
93. Mamali, I., Kotsantis, P., Lampropoulou, M. & Marmaras, V.J. Elk-1 associates 
with FAK, regulates the expression of FAK and MAP kinases as well as apoptosis 
in HK-2 cells. J Cell Physiol 216, 198-206 (2008). 
94. van de Water, B., Houtepen, F., Huigsloot, M. & Tijdens, I.B. Suppression of 
chemically induced apoptosis but not necrosis of renal proximal tubular epithelial 
(LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining 
focal adhesion organization after acute renal cell injury. J Biol Chem 276, 36183-
93 (2001). 
95. Hungerford, J.E., Compton, M.T., Matter, M.L., Hoffstrom, B.G. & Otey, C.A. 
Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 
135, 1383-90 (1996). 
96. Sonoda, Y. et al. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of 
inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of 
FAK in a human leukemic cell line, HL-60. J Biol Chem 275, 16309-15 (2000). 
97. Sonoda, Y., Kasahara, T., Yokota-Aizu, E., Ueno, M. & Watanabe, S. A 
suppressive role of p125FAK protein tyrosine kinase in hydrogen peroxide-
induced apoptosis of T98G cells. Biochem Biophys Res Commun 241, 769-74 
(1997). 
98. Hinson, J.S., Medlin, M.D., Lockman, K., Taylor, J.M. & Mack, C.P. Smooth 
muscle cell-specific transcription is regulated by nuclear localization of the 
myocardin-related transcription factors. Am J Physiol Heart Circ Physiol 292, 
H1170-80 (2007). 
99. Lockman, K. et al. Sphingosine 1-phosphate stimulates smooth muscle cell 
differentiation and proliferation by activating separate serum response factor co-
factors. J Biol Chem 279, 42422-30 (2004). 
100. Mack, C.P. & Owens, G.K. Regulation of smooth muscle alpha-actin expression 
in vivo is dependent on CArG elements within the 5' and first intron promoter 
regions. Circ Res 84, 852-61 (1999). 
101. Lu, J. et al. Coronary smooth muscle differentiation from proepicardial cells 
requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev 
Biol 240, 404-18 (2001). 
102. Seasholtz, T.M., Majumdar, M., Kaplan, D.D. & Brown, J.H. Rho and Rho kinase 
mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and 
migration. Circ Res 84, 1186-93 (1999). 
103. Liu, B., Itoh, H., Louie, O., Kubota, K. & Kent, K.C. The signaling protein Rho is 
necessary for vascular smooth muscle migration and survival but not for 
proliferation. Surgery 132, 317-25 (2002). 
 68
104. Huang, C., Jacobson, K. & Schaller, M.D. MAP kinases and cell migration. J Cell 
Sci 117, 4619-28 (2004). 
105. Park, D. et al. C-FLIP promotes the motility of cancer cells by activating FAK 
and ERK, and increasing MMP-9 expression. Mol Cells 25, 184-95 (2008). 
106. Pirone, D.M. et al. An inhibitory role for FAK in regulating proliferation: a link 
between limited adhesion and RhoA-ROCK signaling. J Cell Biol 174, 277-88 
(2006). 
107. Yagi, Y. et al. Involvement of Rho signaling in PAR2-mediated regulation of 
neutrophil adhesion to lung epithelial cells. Eur J Pharmacol 536, 19-27 (2006). 
108. Torsoni, A.S., Marin, T.M., Velloso, L.A. & Franchini, K.G. RhoA/ROCK 
signaling is critical to FAK activation by cyclic stretch in cardiac myocytes. Am J 
Physiol Heart Circ Physiol 289, H1488-96 (2005). 
109. Parri, M. et al. EphrinA1 activates a Src/focal adhesion kinase-mediated motility 
response leading to rho-dependent actino/myosin contractility. J Biol Chem 282, 
19619-28 (2007). 
110. Gunst, S.J. & Zhang, W. Actin cytoskeletal dynamics in smooth muscle: a new 
paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell 
Physiol 295, C576-87 (2008). 
111. Hirshman, C.A. & Emala, C.W. Actin reorganization in airway smooth muscle 
cells involves Gq and Gi-2 activation of Rho. Am J Physiol 277, L653-61 (1999). 
112. Hirshman, C.A., Togashi, H., Shao, D. & Emala, C.W. Galphai-2 is required for 
carbachol-induced stress fiber formation in human airway smooth muscle cells. 
Am J Physiol 275, L911-6 (1998). 
113. Corteling, R.L. et al. The functional consequence of RhoA knockdown by RNA 
interference in rat cerebral arteries. Am J Physiol Heart Circ Physiol 293, H440-7 
(2007). 
114. Gupton, S.L., Eisenmann, K., Alberts, A.S. & Waterman-Storer, C.M. mDia2 
regulates actin and focal adhesion dynamics and organization in the lamella for 
efficient epithelial cell migration. J Cell Sci 120, 3475-87 (2007). 
115. Beli, P., Mascheroni, D., Xu, D. & Innocenti, M. WAVE and Arp2/3 jointly 
inhibit filopodium formation by entering into a complex with mDia2. Nat Cell 
Biol 10, 849-57 (2008). 
116. Yang, C. et al. Novel roles of formin mDia2 in lamellipodia and filopodia 
formation in motile cells. PLoS Biol 5, e317 (2007). 
 69
117. Lipsky, B.P., Beals, C.R. & Staunton, D.E. Leupaxin is a novel LIM domain 
protein that forms a complex with PYK2. J Biol Chem 273, 11709-13 (1998). 
118. Brown, M.C., Perrotta, J.A. & Turner, C.E. Identification of LIM3 as the principal 
determinant of paxillin focal adhesion localization and characterization of a novel 
motif on paxillin directing vinculin and focal adhesion kinase binding. J Cell Biol 
135, 1109-23 (1996). 
119. Wu, R. et al. Specificity of LIM domain interactions with receptor tyrosine 
kinases. J Biol Chem 271, 15934-41 (1996). 
120. Tachibana, K., Sato, T., D'Avirro, N. & Morimoto, C. Direct association of 
pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. 
J Exp Med 182, 1089-99 (1995). 
121. Sahu, S.N., Nunez, S., Bai, G. & Gupta, A. Interaction of Pyk2 and PTP-PEST 
with leupaxin in prostate cancer cells. Am J Physiol Cell Physiol 292, C2288-96 
(2007). 
122. Chew, V. & Lam, K.P. Leupaxin negatively regulates B cell receptor signaling. J 
Biol Chem 282, 27181-91 (2007). 
123. Kaulfuss, S. et al. Leupaxin, a novel coactivator of the androgen receptor, is 
expressed in prostate cancer and plays a role in adhesion and invasion of prostate 
carcinoma cells. Mol Endocrinol 22, 1606-21 (2008). 
124. Sundberg-Smith, L.J., DiMichele, L.A., Sayers, R.L., Mack, C.P. & Taylor, J.M. 
The LIM protein leupaxin is enriched in smooth muscle and functions as an serum 
response factor cofactor to induce smooth muscle cell gene transcription. Circ Res 
102, 1502-11 (2008). 
125. Kim-Kaneyama, J.R. et al. Hic-5, an adaptor protein expressed in vascular smooth 
muscle cells, modulates the arterial response to injury in vivo. Biochem Biophys 
Res Commun 376, 682-7 (2008). 
126. Avraamides, C. et al. Hic-5 promotes endothelial cell migration to 
lysophosphatidic acid. Am J Physiol Heart Circ Physiol 293, H193-203 (2007). 
127. Sahu, S.N. et al. Association of leupaxin with Src in osteoclasts. Am J Physiol 
Cell Physiol 292, C581-90 (2007). 
128. Gupta, A. et al. Leupaxin is a critical adaptor protein in the adhesion zone of the 
osteoclast. J Bone Miner Res 18, 669-85 (2003). 
129. Watanabe, N., Amano, N., Ishizuka, H. & Mashima, K. Leupaxin binds to PEST 
domain tyrosine phosphatase PEP. Mol Cell Biochem 269, 13-7 (2005). 
 70
130. Deakin, N.O. & Turner, C.E. Paxillin comes of age. J Cell Sci 121, 2435-44 
(2008). 
131. Even-Ram, S. & Yamada, K.M. Cell migration in 3D matrix. Curr Opin Cell Biol 
17, 524-32 (2005). 
132. Cukierman, E., Pankov, R., Stevens, D.R. & Yamada, K.M. Taking cell-matrix 
adhesions to the third dimension. Science 294, 1708-12 (2001). 
 
 
 71
